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ABSTRACT

In vitro expression of human zona pellucida protein 3
Chili-Wei Chen
Old Dominion University
and
Eastern Virginia Medical School
1995

Human zona pellucida protein 3 (hZP3) is the putative
receptor on the zona pellucida of the mature oocyte that
recognizes and binds sperm, and therefore plays a critical
role in fertilization.
A full length cDNA of hZP3 (1278 bp) was amplified from
the human ovary mRNA by reverse transcription-polymerase
chain reaction (RT-PCR). The hZP3 cDNA was subcloned into
PSK and pREP4 expression vectors. The cDNA of hZP3 was
further characterized by restriction mapping, PCR, auto
sequencing and Southern blot analysis by using an internal
oligonucleotide probe, and found to be identical to the one
reported by J. Dean. Using autosequencing, 289 bases were
identified and more than 98% homology was found at the 3'end with the reported sequence, whereas, 224 bases were
identified and more than 91% homology was found at the 5'end. In vitro translation was performed to ensure the
capacity of the cloned cDNA for producing a full length,
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non-glycosylated hZP3 protein (47 kDa). Stable transfection
of a human ovarian tumor cell line, PA-1, was produced by
introduction of the hZP3/pREP4 expression vector construct
using the calcium phosphate precipitation method. Approxi
mately 200 single colonies of the stable-transfected cells
were isolated by the cloning-ring method. Direct PCR, RTPCR, and ELISA were used to identify and select clones; ten
of the isolated clones were found to be positive.
Two of the ten selected clones (SKC-P3-12 and SKC-P319) were used for further studies. Culture medium was
collected from transfected and non-transfected cells
(negative control) , and the samples were purified by wheat
germ agglutinin (WGA)-lectin chromatography and anti-WGA
immunoaffinity chromatography; the final eluted fraction was
concentrated by ultrafiltration with a limiting molecular
weight cut off at 30 kDa. The secreted glycoproteins were
identified by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) with silver staining, Western
blot analysis using a specific anti-ZP3 antibody, and by a
metabolic labelling study using 3H-galactose. Several bands
including a band at 65 kDa, were observed in both non
transfected and transfected medium by silver staining.
Distinct bands were identified by Western blot analysis at
65 kDa and 100 kDa for the recombinant product; solubilized
human zonae pellucidae demonstrated a molecular mass of
native hZP3 at approximately 65 kDa, and was at the same
position identified for the recombinant product. In the
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metabolic study, several distinct bands including the band
at 65 kDa, were identified as biosynthesized glycosylated
recombinant proteins.
In the hemizona assay (a test for sperm-zona pellucida
binding), a significant inhibition (>40%) of binding was
observed in competition studies using a 1:4 dilution of the
WGA-purified recombinant glycoprotein solution. This
material did not affect sperm viability or motility, and
induced a more than 50% increase in the acrosome reaction of
sperm after overnight incubation.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

ACKNOWLEDGEMENTS

I wish to especially thank Dr. Sergio Oehninger, my
dissertation advisor, for his direction and encouragement
throughout the entire course of this study.
I would also like to thank the other members of my
dissertation committee, Dr. Ke-Wen Dong, Dr. Mark Elliott,
Dr. Frank Castora, and Dr. James Yuan, for their support,
suggestion, comments and advice on my research and
dissertation.
Also, my appreciation goes to Dr. William Gibbons, Dr.
Howard White, Dr. Christopher Osgood, Dr. Gary Clark, Dr.
Mary Mahony, Dr. Klaus Hinsch, Ms Linda Adamson, Ms Suzanne
Cartwright, and Mr. Simon Chi for their support, help and
assistance on this study.
Lastly, I want to express my gratitude to my family
and my other friends here in the Jones Institute. It has
been a privilege to work here for the past years.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

TABLE OF CONTENTS

PAGE

LIST OF TABLES...........................................v
LIST OF FIGURES.........................................vi
CHAPTER
I .INTRODUCTION....................................... 1
A.

Human fertilization............................ 1

B. Sperm-egg interaction andhZP3.................. 4
C.

Zona pellucida.................................8

D.

Zona pellucida proteins........................ 9

E. Developmental expression of hZP3 and the
biosynthesis of glycoprotein...................13
F.

hZP3 gene and cDNA............................16

II. SPECIFIC AIMS.................................... 19
A.

Significance................................. 19

B.

Experimental design...........................21

III. MATERIALS AND METHODS............................ 24
A. Materials.................................... 24
1.

Oligonucleotide primers.................... 24

2.

Cell, vectors, and culture supplies........ 24

3.

DNA markers............................... 25

4.

Radioactive materials...................... 25
ii

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission .

5. Enzymes and other chemicals................ 25
6. Non-chemical materials..................... 26
B. Methods....................................... 27
1. Cell culture............................... 27
2. Medium collection from the culturecells..... 27
3. Isolation of RNA........................... 28
Isolation of total RNA from thehumanovary.29
Isolation of mRNA......................... 29
Isolation of cytoplasmic RNA............... 31
4. RT-PCR ....................................32
5. Subcloning of the cDNA of hZP3............. 33
6. 5'-end radioactive labelling of
oligonucleotide probe.......................35
7. Southern blot analysis..................... 35
8. In vitro translation....................... 37
9. DNA purification by CsCl ultracentrifugation.37
10.

Stable transfection........................ 39

11. RT-PCR for the clonal selection of stabletransfected cells.......................... 41
12.

Isolation of genomic DNA................... 42

13. PCR for the clonal selection of stabletransfected cells.......................... 43
14.

Protein purification....................... 43
Purification by WGA-Lectin chromatography... 43
Preparation of anti-WGA immunoaffinity
chromatography............................ 44
iii

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

Protein concentration......................45
15. Protein assay.............................. 46
16. ELISA...................................... 47
17. Metabolic labelling experiment.............. 49
18. Silver-staining of SDS-PAGE.................50
19. Western blot analysis.......................51
20. Hemizona assay............................. 53
21. Acrosome reaction assay.....................55
22. Statistical analysis....................... 56
IV. RESULTS..........................................58
A. Subcloning of full-length cDNA of hZP3......... 58
B. In vitro transcription/translation............. 69
C. Stable transfection........................... 71
D. Isolation and identification of the
recombinant hZP3.............................. 77
E. Biological activity of the recombinant hZP3

85

V. DISCUSSION AND CONCLUSIONS....................... 89
A. Subcloning of hZP3 cDNA....................... 89
B. Expression of hZP3............................ 91
1. Stable transfection........................ 91
2. Expression of hZP3......................... 93
C. Biological functions of hZP3...................98
D. Conclusion.................................... 99
VI. REFERENCES...................................... 100
APPENDICES.............................................108

iv

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

LIST OF TABLES
TABLE

1.

PAGE

Identification of protein secretion of the stabletransfected cell clones by ELISA................... 76

2. Summary of metabolic labelling experiment........... 84

v

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

LIST OF FIGURES
FIGURE

PAGE

1. Sperm-egg interaction during fertilization: The mouse
model.............................................. 5
2. Structure of the zona pellucida filaments: ZP3 (in black)
and ZP2 (in white).................................. 10
3. Restriction digestion analysis of the RT/PCRproduct..59
4. Southern blot analysis of the RT-PCR product........ 61
5. Identification of the hZP3/PSK construct by
restriction digestion and Southern blot analysis..... 62
6. PCR of the cDNA of hZP3 by an internal probe SI..... 63
7. Comparison of the sequence of hZP3 cDNA from the
3'-end sequencing.................................. 65
8. Comparison of the sequence of hZP3 cDNA from the
5'-end sequencing.................................. 67
9. Restriction digestion and Southern blot analysis
of the hZP3/pREP4 construct......................... 68
10. In vitro transcription/translation of the hZP3
(nonglycosylated) protein.......................... 70
11. Identification of the insertion of hZP3 cDNA into
the transfected PA-1 cells by PCR................... 73
12. Identification of the expression of hZP3 mRNA from
the stable-transfected cell clones by RT-PCR.. .......74
vi

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

13 . Isolation of the recombinant hZP3 glycoprotein by
WGA- Sepharose chromatography........................79
14. Separation of the recombinant hZP3 bySDS-PAGE........80
15. Identification of the secretion of the recombinant
hZP3 protein by Western blot analysis................ 82
16. Results of metabolic labelling experiment........... 86
17. Characterization of the biological activity (spermbinding) of the recombinant glycoprotein in the hemizona assay (HZA).................................... 87

vii

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

I. INTRODUCTION

A. Human fertilization

Fertilization is one of the most important and
interesting subjects in the study of human reproduction
because it concerns the first contact between the two
gametes and the very beginning of human life. It occurs as a
series of orchestrated and regulated events that culminate
in the fusion of the sperm and oocyte to form a one-cell
zygote, the obligatory precursor of all cells in the embryo.
Fertilization can be divided into the following
sequence of events: (1) penetration of the cumulus mass by
the sperm cells,

(2) attachment and primary binding of sperm

to the egg's zona pellucida,
reaction,

(3) induction of the acrosome

(4) secondary binding and penetration of sperm

through the zona pellucida, and (5) fusion of the ovum and
spermatozoon and the activation of egg [1-8] .
Gametogenesis is the process of formation and
development of gametes or germ cells. During spermato
genesis, the chromosome number is reduced by half (haploid),
and the shape of the cells is altered. A mature sperm cell
must undergo two meiotic divisions and a process of
differentiation which takes about sixty-four days to be
1
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completed. The mature sperm cell is a free-swimming,
actively motile cell consisting of three regions, namely
head, neck, and tail. The head contains the haploid nucleus,
and the anterior two thirds of the nucleus is covered by a
head cap known as acrosome which contains a large array of
powerful hydrolyzing enzymes and structural proteins [7,9,
10]. Among these enzymes, hyaluronidase and acrosin are the
two acrosomal enzymes that have been most extensively
studied and well characterized. It seems likely that a high
degree of acrosomal organization may be required to assure
the release of acrosomal components in a precise order as
the spermatozoa penetrate through the egg's zona pellucida
[7,9,11]. Interestingly, glycoprotein is a major component
of the acrosomal matrix [11-13] and therefore is supposed to
be important in many physiological functions of sperm during
fertilization, including the conversion of proacrosin into
enzymatically active acrosin [14-17]. Mitochondria are
abundant in the proximal portion of the sperm tail,
supplying the energy for the vigorous sperm motility [1,2,7,
18] .
Spermatozoa that have matured in the epididymis are
capable of moving actively, yet they still have to undergo
the process known as capacitation to gain the capacity for
fertilization after residing in the female tract for some
period of time [19,20] . Even though the molecular basis is
not fully understood, capacitation is believed to involve a
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variety of metabolic/biochemical changes in preparation for
fertilization [1,21].
Under in vitro conditions, and after about two hours
of contact with capacitation medium, the spermatozoa begin
to move much more actively than ever before. They swim in a
characteristic movement seen as a very vigorous whiplashlike
beating of the tail, often with the sperm head tracing an
erratic figure-eight pattern (also known as nonprogressive
or dancing movement) interspersed with brief episodes of
linear movement. This is known as hyperactivity motility.
The strong thrusting power generated by the vigorous tail
movements may facilitate spermatozoa in swimming through the
viscous fluid of the oviduct [18,22-24] as well as the
relatively thick zona pellucida [1,7,15,19,20,22,23,25,26].
Acrosome reaction as well as hyperactivity motility
are the outcome of the capacitation process. The healthy
sperm have to go through this modification step (capacita
tion) , especially the modification of the composition of the
cytoplasmic membrane, in order to make themselves suitable
for a successful physiological response during acrosomal
exocytosis and fertilization events [3,7, 8,21].
Many compounds have been found to demonstrate the
ability for activating the acrosome reaction, for example,
follicular fluid, hyaluronidase, calcium ionophores, and
zona pellucida proteins. In fact, a large fraction of sperm
lose their acrosomes before they reach the surface of zona

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

4

pellucida during their penetration through the cumulus
matrix. Although both of the acrosome-intact and acrosome reacted sperm cells are able to attach to the zona pellucida
in the mouse, the species best characterized so far, only
the acrosome-intact ones are found to be capable of tight
binding to the zona pellucida [7,17,27-36].
Zona pellucida protein 3 (ZP3) and zona pellucida
protein 2 (ZP2) are, respectively, thought to be the first
receptor and the second receptor for the specific
recognition and binding between the zona pellucida and the
sperm cells, but the detailed mechanism of their interaction
is still unknown [4,6,37-39]. Generally speaking, the
mechanism of acrosome reaction and even the individual
physiological functions of the activators of the reaction,
are still not clear.

B. Sperm-egg interaction and hZP3

In the mouse, sperm-egg interaction during
fertilization consists of a sequence of events that take
place in a compulsory order as follows (Fig 1) [2,5,7,8,
15,18,39]:
1)

First of all, the sperm cells pass through the

corona radiata and contact the oocyte. At this step, the
attachment is random, loosely associated and not speciesspecific. Therefore the attached sperm can be usually washed
away by simple agitation, and this is one of the most
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Fig 1. Sperm-egg interaction during fertilization: The mouse
model. The picture is adapted and modified from reference
(54). According to this model, a spermatozoon recognizes and
binds with ZP3 (primary receptor in the zona) ,- this is
followed by induction of the acrosome reaction by ZP3 in the
zona-bound sperm cell; after this, a secondary sperm
receptor is exposed and interacts with ZP2. This is followed
by zona pellucida penetration.
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important steps of the hemizona assay (HZA) method which
will be discussed in a later chapter.
2) Subsequently, some spermatozoa bind tightly and
specifically with the oocyte via the interaction between
sperm and oocyte receptors, i.e. ZP3 and its corresponding
sperm receptor. This process is defined as the tight binding
event. Unlike the previous attachment event, tight binding
is thought to be irreversible, and it is generally agreed
that tight binding is required to allow penetration of the
specialized covering of the ovum, the zona pellucida [29] .
3) The acrosome reaction is the next event that
follows the tight binding event. During fertilization, this
organelle has to break to release its contained enzymes to
enhance the penetration of the sperm into the zona
pellucida. As we mentioned before, some sperm cells'
acrosomes are broken during their penetration process
through the cumulus matrix and follicular fluid, but only
the acrosome-intact ones have the potential to penetrate the
extremely thick extracellular matrix surrounding the ovum
and fertilize the ovum. The acrosome reaction occurring
between the intact sperm and the zona pellucida can be
divided into two steps: (1) fusion of the outer acrosomal
membrane and sperm plasma membrane, and (2) releasing of the
associated enzymes and small membrane vesicles from the
sperm head and inner acrosomal membrane. It is believed that
the acrosome reaction is a signal transduced exocytosis
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process involving at least two of the protein kinase systems
(protein kinase A and protein kinase C) [4,36,40,41], but
the detailed mechanism is still to be clarified [16,30,31] .
4) The acrosome-reacted sperm cells are the only ones
that have the chance to penetrate the zona pellucida and
reach the perivitelline space. Normally only one of them is
able to be the first and the unique one to fuse with the
plasma membrane of the ovum, and then get into the ovum to
form a zygote [29,32,42] .
5) Then the development of the zygote starts.
Meanwhile, the electrical potential of the egg plasma
membrane changes almost immediately after the spermatozoon
reaches the ovum. The plasma membrane of the egg becomes
"hardened" in seconds due to these effects, and therefore
blocks additional sperm binding and penetration.
6) The zona pellucida is modified and becomes
"hardened" by the releasing of enzymes from the cortical
granules which are membrane bound, lysosome-like organelles,
occupying a region of the egg cytoplasm just beneath the
plasma membrane. The cortical granules which accumulated
during oocyte growth as a product of the Golgi body, fuse
with the egg plasma membrane and release their contents into
the perivitelline space. This so called "zona reaction"
happens in seconds after fertilization.
Among all these events, the event that influences the
sperm binding to the zona pellucida is an initial, crucial

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

8

recognition step leading to fertilization. Recent investi
gations into the molecular composition and genetics of the
zona pellucida and sperm membrane receptors have provided
much more detailed information about the molecular basis of
this critical event during fertilization, especially in the
murine species. It is well accepted that ZP3 has a major
role on the specific, primary sperm binding to the zona, and
has the potential to induce the sperm's acrosome reaction.
This follows studies using both crude solubilized mixture of
zonae pellucidae as well as intact eggs in the mouse model,
which is the best characterized species so far in ZP3
research [4,9,30,37,38,40,43].

C. Zona pellucida

Beginning at puberty, as the primary oocyte ensues
development, the single layer of flattened, follicular
epithelial cells surrounding the egg become cuboidal and
then columnar, forming a primary follicle. The primary
oocyte soon becomes surrounded by a covering of amorphous
intercellular material known as the zona pellucida. In fact,
the zona pellucida is a very thick and unique extracellular
matrix surrounding the female gamete, constituted by zona
pellucida fibers in a specific manner [28,44-46] . Compared
to the oocyte itself, the thickness of the zona pellucida is
more than half of the radius of the ovum inside depending on
the species and the stages of the growing follicle [5,7] .
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The organization of the human zona pellucida is not
yet clear, whereas the evidence obtained from immunohistochemistry and autoradiographic visualization demonstrate
that at least two layers of organization exist in the human
zona pellucida [28,44,45]. Each fiber is composed of several
individual filaments in the mouse model and it may be
similar in the human [44] .
It is believed that ZP3 and ZP2, which are two of the
major components of the zona pellucida, bind together to
form a dimer and the dimer acts as the building subunit of
the zona filament (Fig 2). Another glycoprotein, ZP1 which
is also abundant in the zona pellucida serves as linker
between zona filaments and ZP3-ZP2 dimer subunits [7].

D. Zona pellucida proteins

The zona pellucida proteins (ZP1, ZP2, and ZP3) are
distinguished from each other by differences of their
characteristic migration positions on denaturing gel
electrophoresis (SDS-PAGE). ZP3 is believed to be the
primary sperm receptor, and ZP2 the secondary sperm
receptor, whereas the function of the ZPl is structurerelated [18,44,47].
Both the mouse and human ZP3 proteins are composed of
424 amino acids, and are 67% identical in their amino acids
composition with the greatest similarity in the center of
the protein. The human ZP3 protein (12% acidic, 8% basic,
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Fig 2. Structure of the zona pellucida filaments: ZP3 (in
black) and ZP2 (in white). In addition, ZP1 protein is
another major component in the zona pellucida filament, but
it is structure related, and is not shown in the figure. The
arrow signs represent different oligosaccharides which are
responsible for the recognition and binding with the sperm
cell.
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7% aromatic, and 32% hydrophobic residues) has a calculated
molecular mass of 47.032 Da (nonglycosvlated) [40] .
ZP3 has a very hydrophobic region consisting of 26
amino acids near the carboxyl terminus which may play an
important role in the intracellular trafficking of these
secreted proteins or in their interactions in the extra
cellular matrix [39,40].
In the mouse, the ZP3 is believed to have 3-6 complextype N-linked carbohydrate side chains, and an undetermined
number of 0-linked sugars [5,39]. The 0-linked oligo
saccharides on ZP3 have been identified as the primary
sperm-binding moiety [48] , and galactose and N-acetylglucosamine are two carbohydrates that have been implicated
as essential for the sperm receptor activity of the zona in
mice [49] . ZP3 and ZP2 share one common structure motif with
a very hydrophobic region consisting of 23 and 26 amino
acids respectively, near the carboxyl terminus. In the
mouse, the ZP3 polypeptide chain has a 22 amino acids signal
sequence for the glycosylation of the protein at its Nterminus [5,39,40,50-52].
Once the zona pellucida proteins are incorporated into
the extracellular matrix, they are found to be very stable
and have a long half-life, and it is estimated that the zona
pellucida proteins in the natural conditions maintain their
biological activities for days (>100 hr) [39].
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Compared to the mouse zona pellucida (mZP) , less
information is available for the human zona pellucida (hZP).
In the human, the acrosome-initiating activity of intact and
solubilized human ZP has been reported [30,32,34,42] .
However, these experiments are all performed by using very
crude mixture samples with almost all of the zona pellucida
components in it. Whether hZP3 alone or multi-components are
necessary for the induction of the acrosome reactionof
human sperm is still unclear. However, the intact and
tertiary structure of ZP3 is suggested to be critical for
the induction effect of the acrosome reaction [6,9] .
Similar to the mouse,

the human zona pellucida isalso

composed of three major glycoproteins: ZP1, ZP2, and ZP3.
Besides, two isoforms of human ZP3 have been reported, named
ZP3h and ZP3L, but whether they represent different posttranscriptional modifications of a single ZP3 gene product,
the presence of an additional gene, or they simply just
demonstrate the heterogeneous glycosylation products remain
to be clarified [39,40,42,53].
The molecular weights of human zona pellucida proteins
are species-related and demonstrate heterogeneity due to
various degrees of glycosylation. According to J. Dean, the
molecular mass of human zona pellucida proteins are:
ZP3. from 57 to 73 kDa.- ZP2, from 64 to 76 kDa; and ZP1,
from 90 to 110 kDa [39] . The human ZP3 has a polypeptide
backbone of 424 amino acids with complex type N-linked and
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O-linked oligosaccharide side chains [39]. The human
polypeptide chain contains four potential N-linked
glycosylation sites, and sixty-six potential O-linked
glycosylation sites [40].

E. Developmental expression of hZP3 and the biosynthesis of
glycoprotein

The synthesis of zona pellucida proteins is first
detected when oocytes enter their two weeks growth phase
before ovulation [39] . Investigation in the mouse model has
concluded that the zona pellucida proteins are synthesized
in only growing oocytes and secreted into the extracellular
matrix [54-61] .
In a mouse experiment, various sizes of oocyte
follicles in the ovary were isolated and the expression of
ZP3 was monitored by the ratio of its mRNA among total RNA.
At its peak in 30-35 fim diameter oocyte, zona pellucida
synthesis represented 7-8% of total protein synthesis. Zona
production declined in the fully grown oocyte and was absent
or not detectable in ovulated eggs and the embryo [39] . In
the ovulated eggs, the mRNAs of ZP2 and ZP3 are found to be
200 nucleotides shorter than those found in the growing
oocyte, implying the possibility of developmental regulation
of the expression of the ZP gene between these two phases of
the oocyte [56] . The mechanism for the regulation of the
oocyte-specific and developmental expression of the ZP3 gene
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is still not clear, although it is believed the hormones and
cytokines may play important roles on these functions [7].
Little is known on the human zona pellucida due to the
difficulty in obtaining human oocytes and zona pellucida
protein. Therefore, it was believed to be necessary to apply
molecular biology techniques to supply enough hZP3 for
investigation. Recent work reported an established Chinese
Hamster Ovarian cell line (CH0-K1) transfected with a hZP3reconstructed mini-gene which was capable of expressing a
recombinant hZP3 glycoprotein. However, the reported
molecular mass was at least 5 kDa lower than the native hZP3
protein. The biological activity of the recombinant hZP3
protein was only reported in acrosome reaction assays and
sperm-egg fusion assays. The most important biological
activity, that is the sperm ligand capacity, was not
reported [62].
Since hZP3 is a glycoprotein, and the oligosaccharides
have been proven to be critical for the biological functions
of sperm-egg interaction [29,39,48-50,52,63-65], it is
believed that the biological activity of the hZP3 is
dependent on the secondary modification of the polypeptide
backbone, that is the glycosylation. The glycosylation of a
protein is thought to be species-dependent due to the
different "glycosylation machinery" in various cell types,
therefore, it is of highly interest to study the production
of recombinant hZP3 glycoprotein in human ovarian cell
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lines. In addition, the "glycosylation machinery" is
organized by the Golgi body and rough endoplasmic reticulum
(RER), including their constituted glycosylation-related
enzymes, and peptidyl-receptors. In addition, oligo
saccharide -carriers, and the sugar transportation systems of
the cell itself are also important for the biosynthesis of a
glycoprotein.
It is believed that hZP3 has three complex type
N-linked (asparagine-linked) oligosaccharide side chains and
an unknown number of complex type O-linked oligosaccharides
[39]. Typically, these two types of oligosaccharides in hZP3
glycoprotein are both rich in galactose. The complex type
asparagine-linked oligosaccharides contain a variable number
of outer chains linked to a core of N-acetylglucosamine and
mannose. The outer chains are consist mostly of galactose
and sialic acid. In the complex type O-linked oligo
saccharides, a similar core exists which is also rich in
galactose residues (typically, >50%) [66-68].
One obvious difference between the biosynthetic
pathways of these two types of oligosaccharides lies in the
involvement of the oligosaccharide-pyrophosphate-dolichol
(oligosaccharide-P-P-Dol) which is necessary for the
biosynthesis of N-linked oligosaccharide but not O-linked
oligosaccharides.
The pyrophosphate-dolichol (P-P-Dol) is important for
the transportation of N-linked oligosaccharide, and
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therefore the biosynthesis of N-linked oligosaccharide is
dependent on the concentration of intracellular P-P-Dol. It
is expected that P-P-Dol plays a crucial role for the
regulation of glycosylation and biosynthesis of a glyco
protein. The assembling, transferring, and processing of the
oligosaccharide-P-P-Dol is finished in the RER and the
product is localized on the inner membranes of the RER.
Actually the glycosylation of all

glycoproteins is started

at the inner membrane of RER. And generally speaking, most
of the modification, addition and deletion processes of the
oligosaccharides of the glycoproteins is completed in the
Golgi body.

F. hZP3 gene and cDNA

The human ZP3 gene is comprised of eight exons and the
overall structure of the zona genes and their products is
thought to be conserved among mammals. Using cross
hybridization with mouse nucleic acid sequences as a
criterion, the conservation of ZP3 genes of human is more
related to mouse than that of pig and rabbit [39,40] .
Similar to mouse and hamster, the human ZP3 mRNA has
short 5 ' and 3' untranslated regions which are very unusual
and characteristic among all species found. The polypeptide
of human ZP3 deduced from the open reading frame of its mRNA
has a molecular mass of approximately 47 kDa and consists of
424 amino acids [1,28,69-71].
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The characterization of the cDNA encoding mouse ZP3
has made the expression of recombinant ZP3 (rZP3) in tissue
culture lines possible and represents a potential option for
obtaining large amounts of murine ZP3. However, since
glycosylation appears mandatory for ZP3-ligand function, it
has been unclear whether rZP3 obtained from cells other than
oocytes would possess the necessary post-translational
modifications required for biological activity [37] .
Recently, a full length cDNA encoding mouse ZP3 was
cloned into expression vectors [37]. Mouse L-929 cells and
green monkey cells were transfected with the mouse ZP3expression vector constructs, and the recombinant mouse ZP3
protein (rmZP3) was purified by immunoaffinity chromato
graphy from the culture medium and detected on Western blots
using a mouse monoclonal antibody against an oligosaccharide
side chain of hZP3. Although this rmZP3 differed slightly
from native mZP3 in its molecular mass, it demonstrated
biological activity in homologous murine sperm-zona
pellucida competition assays and in triggering mouse
acrosomal exocytosis in capacitated mouse sperm. Thus,
according to these authors, rmZP3 isolated from both rodent
and primate cells appears to contain those carbohydrate and
protein structures necessary for ZP3's dual role in
fertilization in the mouse.
Another approach has been tried by introducing a hZP3minigene construct into the Chinese Hamster cell line (CHO-
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Kl) , but the recombinant hZP3 produced was at least 5 kDa
lower in molecular mass even though the transfection process
seemed to be successful. As discussed previously, the
biological activity was not satisfactory [62] . These facts
imply that the glycosylation process of hZP3 in the
transfected host cell may be critical for the expression of
biologically active hZP3.
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II. SPECIFIC AIMS
The specific aims of this study are:

(1) To produce a full-

length cDNA of hZP3 and to express human ZP3 in a human
ovarian cell lines (PA-1) ; and (2) To characterize the
biological activity of the recombinant product as sperm
ligand and acrosome reaction inducer.

A. Significance

Many couples suffer from infertility, but in some of
the cases the pathophysiological causes are still unclear.
This mainly applies to male-factor infertility, where many
cases are still considered "idiopathic", or, in other words,
the cause is unknown. Even though in vitro fertilization
(IVF) and other assisted reproductive techniques have been
widely and successfully applied to these problems, little is
known about their pathological origin, and the efficiency of
the therapy is actually low and depends on an uncertain
principle of "getting the gametes closer together". Because
of our lack of complete understanding in the molecular
details of fertilization, there is not an accurate and
satisfactory tool or assay to assess all of these sperm
dysfunctions. Recently, cellular and molecular advances in
gamete biology have elucidated the structure and interaction
19
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of the binding receptors on the surfaces of both sperm and
egg, principally in the mouse model. It is very interesting
for us to study the binding receptors in human species by
using molecular biology techniques.
Among several molecules involved in the event of
fertilization, ZP3 protein is believed to be the first
receptor in the zona pellucida that specifically recognizes
and binds with the sperm. Therefore, ZP3 may play a very
important role in fertilization, as determined during the
pathophysiological study of some potential causes of male
infertility and in the clinical diagnosis of fertility. In
addition, ZP3 has been reported to be highly immunogenic
[53,72-74] and therefore ZP3 may also be critical for the
design of long-term immunocontraceptive methods.
The difficulty in obtaining enough human oocytes and
preserving solubilized hZP3 protein has made further studies
difficult due to the scant natural source of human ZP3.
Therefore we sought to produce a stable transfected cell
line to supply enough recombinant human ZP3 with biological
activity for further studies by using molecular biology
techniques.
The information provided by this study could have
significant impact in many areas within the Reproductive
Biology/Medicine field: (1) the physiology of human spermzona pellucida interaction and pathophysiology of the
clinical disorders affecting human fertilization may be
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critically reviewed and expanded (i.e., temporal relation
ship between zona binding and penetration, acrosome reaction
and motility patterns, isolation of the putative ZP3
receptor from human sperm, etc.); (2) a solid or liquid
phase assay may be developed using the artificial (re
combinant) ZP3 thus giving access to a much simpler and
universally applicable clinical diagnostic method to assess
human sperm-zona pellucida interaction; and (3) the
generation of a "naturally" glycosylated recombinant ZP3 may
be exploited for engineering a contraceptive vaccine against
the human zona pellucida and therefore advance fertility
regulation research.

B. Experimental design

Our initial approach consisted of the isolation of
mRNA from the human ovary, followed by the use of RT-PCR for
generation of a full length cDNA for human ZP3. The cDNA was
then purified by the geneclean glass-milk method and was
respectively subcloned into PSK and pREP4 expression
vectors. Autosequencing, Southern blot analysis, restriction
mapping, PCR and in vitro translation were performed to
identify the cDNA of hZP3.
The hZP3/pREP4 DNA construct was stably transfected
into human ovarian PA-1 cell line by the calcium phosphate
precipitation method. Single colonies were isolated by the
cloning-ring technique [75]. PCR was performed to confirm
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the integration of the inserted cDNA into the genomic DNA of
the host cell. Because that the mRNA of zona pellucida
proteins are expressed in the oocytes at their two-weeks
growth phase before ovulation, and there is little or no
mRNA of ZP3 found in ovulated oocytes in the study of the
mouse model [39,57], there will be no mRNA expected in the
non-transfected PA-1 cells. RT-PCR was performed to identify
the expression of the inserted cDNA in transfected cells.
Identification of the production of hZP3 protein was
performed by ELISA and Western blot analysis. A metabolic
labelling study by substitution of 3H-galactose in the
culture medium was performed to identify the glycosylated
product of hZP3 expression. Solubilized human zonae
pellucidae were used as positive controls. Lectin-affinity
chromatography, immunoaffinity chromatography and ultra
filtration were used for protein isolation and purification.
The biological activity of the recombinant ZP3 was
assessed in two ways: (1) The capacity of the recombinant
protein to compete (competitive inhibition) with the natural
zona pellucida for sperm binding was examined by the
hemizona assay. Dose-response studies were performed to
determine the efficiency of the recombinant ZP3 as a sperm
ligand, and sperm motility was also monitored to further
characterize the biological activity. (2) The capacity of
the recombinant protein to induce a "physiologic" acrosome
reaction was assessed by using lectin staining (Pisum
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sativum agglutinin) staining combined with immunofluorescent
techniques. Consequently, the criteria used for the identi
fication of the secreted recombinant protein were immunogenicity, molecular mass, and biological activity.
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III. MATERIALS AND METHODS

A. Materials

1. Oligonucleotide primers:
Oligonucleotide primers (CH-1, CH-2, and SI primers)
were designed for this study as follows: CH-1 primer
(5' ACCATGGAGCTGAGCTATAGG 3') and CH-2 primer
(5'TTATTCGGAAGCAGACACAGG 3') were purchased from Oligos,
Etc. (Wilsonville, OR). SI primer (5' GTCAGCCGGGCCTTCCACTGG
3') was synthesized at the Microbiology Department, EVMS.
(Dr. Stenberg)

2. Cells, vectors and culture supplies:
A human ovarian tumor cell line, PA-1, was purchased
from American Type Culture Collection (ATCC CRL 1572,
Rockville, MD). XLl-Blue Ecoli cells were from Strategene
(La Jolla, CA). pBluescript SK (+) vector (PSK) was
purchased from Stratagene. A mammalian cell expression
vector, pREP4, was purchased from Invitrogen (San Diego,
CA). Trypsin-EDTA solution and minimum essential medium
eagle (MEM) were purchased from Sigma (St. Louis, Mo). Fetal
bovine serum (FBS) was from Hyclone (Logan, Utah), Ham's F10 was from Gibco Lab (Grand Island, NY).
24
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3. DNA markers:
DNA molecular weight marker III was purchased from
Boehringer Mannhein (Indianapolis, IN), and 123 DNA ladder
was from Gibco BRL technologies (Grand Island, NY).

4. Radioactive materials:
[7"32P] -Deoxyadenosine 5'-triphosphate for radioactive
labelling of oligonucleotide probe and 35S-methinine
(translation grade) for in vitro translation were purchased
from Du-Pont NEN (Boston, MA) . 13C-protein rainbow marker
(14.3-200 kDa) for fluorography was purchased from Amersham
(Arlington Heights, IL).

5. Enzymes and other chemicals:
Restriction enzymes used in recombinant DNA procedures
were purchased from New England BioLabs (Beverly, MA),
Promega (Madison, WI) and Boehringer Mannheim.
Most of the chemical materials purchased from Sigma
Chem. Co. (St. Louis, MO) except the following materials:
TNT T3 Couple reticulocyte lysate (for in vitro
translation), polytract mRNA isolation kit, Magic Maxiprep
kit (for plasmid DNA isolation), T4 polynucleotide kinase,
alkaline phosphatase (Calf intestine), Tag polymerase (for
"direct PCR" and "RT-PCR diagnosis", see Methods), lysozyme,
RNasin and dNTPs were purchased from Promega. Taq polymerase
(for production of full length cDNA of hZP3), Proteinase K,
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IPTG (isopropyl-beta-thiogalactopyranoside) and X-Gal (5bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) were
purchased from Stratagene. M-MLV reverse transcriptase, DTT
and oligo(dT) 12.lg were from Gibco BRL. (FITC)-labeled Pisum
Sativum agglutinin (PSA), Vectastain Alkaline Phosphatase
ABC kit, BCIP/NBT kit, Wheat germ agglutinin (WGA) lectin
and anti-WGA antibody were from Vector (Burlingame, CA) . The
non-radioactive protein rainbow marker (14.3-200 kDa) was
purchased from Amersham, Geneclean glassmilk (for DNA
isolation) was purchased from Biol 101 (La Jolla, CA) , BCA
protein assay kit was from Pierce, sheared salmon sperm DNA
was from 5 prime -> 3 prime Inc. (Boulder, CO), TMB (for
ELISA) was purchased from Pierce (Rockford, IL), peroxidaseGoat-anti-rabbit-IgG (H+L) was from Zymed (San Francisco,
CA) and fluorographic amplification reagent was purchased
from Amersham.

6. Non-chemical materials:
Most of the non-chemical supplies were purchased from
Fisher (Pittsburgh, PA), or Costar Corning (Cambridge, MA)
except the following materials.
PCR reaction tube was purchased from Perkin Elmer
(Norwalk, CT), Whatman 3 MM paper was from Schleicher &
Schuell (Keen, NH), dialysis tubing (3500 Da MW cut off) was
from Spectra (Houston, TX), X-ray film (Fuji RX) was from
Fisher, nitrocellulose membrane (0.45 /xm) was from Costar
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and Centricon and Centriprep (with 30 kDa cut-off) were
purchased from Amicon (Beverly, MA).

B . Methods
1. Cell culture

PA-1 (ATCC CRL) and the transfected cells were
cultured with MEM containing 10% FBS [77,78]. Typically,
confluent cells were split at 1:6 dilution in MEM containing
10% FBS. The stable transfected cells were maintained in MEM
with 150 /ig/ml of hygromycin (antibiotic) for at least three
weeks to establish the stable transfection cells, and then
the culture was continued in regular medium for further
application [76]. FBS with 9% Dimethylsulfoxide (DMSO) was
used as cryogenic medium for the storage of cells. The cells
were spun down, washed by PBS buffer, resuspended in the
cryogenic medium, and then frozen in liquid nitrogen
following standard procedures.

2. Medium collection from the culture cells

For ELISA, the culture medium was collected when the
cells reached 70% confluence to get a detectable amount of
the recombinant glycoprotein secreted. The collected medium
was centrifuged promptly to separate the supernatant, and
protease inhibitors (1.0 mM PMSF, 0.7 mg/ml Pepstatin A, 0.5
mg/ml Leupeptin, and 1.0 mM EDTA) were added. The samples
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were stored at -80 °C until used [79] .
For the isolation of the recombinant glycoprotein by
the chromatography method (described later), culture medium
was collected in short periods of culture by using the
following procedure: Cells were adjusted to 15% confluence
in medium (MEM) containing 10% FBS, cultured for 4 hr to
allow cells to attach to the plate, washed once with PBS to
remove the suspended cell bodies. Then culture medium was
changed by 5.0 ml of fresh MEM with 10% FBS. Culture medium
was collected every 12 hr until the cells reached 70%
confluence. The collected medium was treated as above
description (protease inhibitors added and centrifuged
promptly) and stored at -20°C until used.

3. Isolation of RNA

Glassware used for the RNA isolation was all baked at
200°C overnight. Plastic centrifuge tubes were thoroughly
rinsed before usage with washing solution (0.1 N NaOH, 1.0
mM EDTA), and then rinsed with RNase-free water. Other
plasticware was soaked in 0.05% diethyl pyrocarbonate (DEPC)
overnight to remove the organic impurity and then autoclaved
for 30 min to degraded residual DEPC. All solutions were
treated with 0.05% diethyl pyrocarbonate (DEPC) overnight at
room temperature and then autoclaved for 30 min to remove
any trace of DEPC.
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Isolation of total RNA from the human ovary

Total RNA was isolated by modifying Chirwin's
guanidine thiocyanate method [80]. "Denaturing solution" was
prepared by adding 132.0 ml of CSB buffer (0.042 M sodium
citrate, 0.028 M N-lauroylsarcosine, 0.0014% mercaptoethanol, pH 7.0) to 100.0 g of guanidine thiocyanate. An
aliquot of 12.0 ml of "denaturing solution" was dispensed
into a sterile 50 ml centrifuge tube and chilled on ice for
5 min. Approximate 1.0 g of human ovary was chopped into
small pieces by sterile surgical knife, transferred into the
denaturing solution, and homogenized by a polytron. After
1.2 ml of sodium acetate solution (2.0 M, pH 4.0) was added
to the lysed cell solution, the RNA was extracted with 12.0
ml of phenol:chloroform:isoamyl alcohol (25:24:1). The RNA
was precipitated at -20°C overnight by adding 1 volume of
isopropanol. The RNA was pelleted by centrifugation at
10,000 x g for 15 min at 4°C, washed with 12.0 ml of 75%
ethanol, dried in a vacuum desiccator for 20 min, and then
dissolved in RNase-free water for storage at -20°C. Finally,
the concentration of RNA was determined by measuring the
absorbance at 260 nm [81].

Isolation of mRNA

The mRNA was further purified by the method of
polytract mRNA isolation system following manufacturer's
description (Promega). A biotinylated oligo(dT) primer was
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used in the system to hybridize to the 3'poly(A) region
present in eukaryotic mRNA species. The mRNA-biotinylated
oligo(dT) hybrids were captured by paramagnetic particles
which were pre-coupled with streptavidin at high stringency,
washed thoroughly and then isolated by using a magnetic
separation stand. The mRNA was eluted from the solid phase
with RNase-free water.
One milligram of total RNA isolated as described above
was brought to a final volume of 500 /liI in RNase-free water.
For the purpose of annealing of biotinylated-oligo-(dT)ms
primer with the mRNA, the total RNA solution (500 fil) was
incubated at room temperature for 10 min by adding 3.0 n± of
the biotinylated-oligo (dT) 12.18 primer and 13.0 /xl of 20 x SSC
(3.0 M NaCl, 0.3 M sodium citrate, pH 7.0).
Streptavidin-coupled magnetic sphere particles (SAPMPs) were prepared by gently flicking the bottom of the
tube until completely dispersed, and captured by placing the
tube in the magnetic stand. The SA-PMPs were collected at
the side of the tube, washed three times with 0.5 x SSC (0.3
ml each) and then resuspended in 0.1 ml of 0.5 x SSC.
In order to isolate the mRNA, the entire content of
the annealing reaction above was added into the tube which
contained the washed SA-PMPs, and the reaction was incubated
at room temperature for 10 min. Then the mRNA-oligo(dT)
hybrids were captured by SA-PMPs, washed four times with 0.1
x SSC (0.3 ml per wash) , and then eluted from SA-PMPs by
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two fractions of 0.1 ml of RNase-free water. The eluted mRNA
solution was centrifuged again at 10,000 x g at 4°C in order
to remove the magnetic particles.

Isolation of cytoplasmic RNA (sucrose gradient method)

For the purpose of clonal selection of the stable
transfected cells by RT-PCR, the total cytoplasmic RNA was
isolated by sucrose gradient method as follows: A plate of
70% confluent cells was washed with sterile PBS, and then
the cells were scrapped out from the petri dish by a rubber
policeman with 500 /xl of lysis buffer (1.5 mM MgCl2, 0.5%
NP-40, 0.25% Sodium deoxycholate, 0.3 M sucrose, 10.0 mM
Tris, pH 7.4) on ice. The cell lysate was carefully laid
onto a 350 /xl of Cushion buffer (1.5 mM MgCl2, 10.0 mM Tris,
0.4 M sucrose, pH 7.4) and spun at 5000 x g for 10 min at
4°C. A 500 /x1 fraction of the upper aqueous solution was
transferred to a fresh tube. Then 58.0 /xl of 10 x STE buffer
(0.1 N NaCl, 10.0 mM Tris, 1.0 mM EDTA, pH 8.0) , 12.0 /xl of
10.0 mg/ml of proteinase K, and 17.0 /xl of 5.0 M NaCl were
added. The mixture was incubated at 45°C for 45 min,
extracted with equal volume of phenol:chloroform (1:1). The
RNA was precipitated overnight at -20°C with equal volume of
isopropanol, spun down and washed once with 1.0 ml of 70%
ethanol. The RNA pellet was dried and dissolved in RNasefree water. The quality of RNA was assessed spectrophotometrically (A^/A^) and by agarose gel electrophoresis [81].
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4. RT-PCR

The purified mRNA was reversed transcribed to cDNA,
and then the hZP3 cDNA was specifically amplified by PCR.
The RT reaction was performed as follows: One microgram of
mRNA, 20.0 units of RNasin, 100.0 pmol oligo(dT) 12.18, 1.0 mM
of each dNTPs (dATP, dTTP, dCTP, and dGTP), 10.0 mM DTT and
100 U of M-MLV reverse-transcriptase were added in 5 x first
strand buffer (250 mM Tris-HCl (pH 8.3), 375 mM KC1, 15.0 mM
MgCl2), and the final volume was added up to 20.0 /xl by
DEPC-treated water. The reaction was performed at 37°C for
30 min, then at 42°C for 15 min, stopped by incubation at
95°C for 5 min and chilled on ice at once [83] .
The RT reaction above was directly applied to a PCR.
The PCR was accomplished by using a pair of 21 base-pairs
(bp) oligonucleotide primers (CH-1 primer and CH-2 primer,
see Materials) designed based on the published sequence of
the cDNA of human ZP3 [40]. The synthesized first-strand
cDNA (20.0 /xl) described above was denatured at 100°C for 3
min and then amplified by PCR with 2.5 U Taq polymerase by
adding 15 pmole of each CH-1 and CH-2 primers and 10.0 /xl of
10 x PCR reaction buffer (100 mM Tris-HCl (pH 8.8), 500 mM
KC1, 15.0 mM MgCl2, 0.1% (w/v) gelatin) in a final reaction
volme of 100 /xl. The thermocycler was programmed as follows:
94°C denaturing for 1 min, 55°C annealing for 1 min, and 72°C
extension for 30 sec with a 2 sec extension per cycle, for a
total of 35 cycles of amplification, followed by final
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extension at 72°C for 3 min [83]

5. Subcloning of the cDNA of hZP3

The RT-PCR product was blunt-end ligated with EcoRI
linkers, and then inserted into the PSK vector. In order to
create blunt-ends, the RT-PCR product was subjected to a
fill-in reaction at room temperature for 30 min by adding
2.5 mM of each dNTPs and 2.5 U the Klenow (large fragment of
DNA polymerase I). For blunt-end ligation, EcoRI linkers
were phosphorylated by T4 polynucleotide kinase. The fill-in
reaction was heat-inactivated at 75°C for 20 min and then
combined with the linker reaction prepared above. This was
followed by addition of T4 DNA ligase and 10 x ligase buffer
(500 mM Tris-HCl (pH 7.8), 100 mM MgCl2, 100 mM DTT, 10.0 mM
ATP and 500 /ig/ml BSA) , and incubated for 5 hr at 15°C for
the purpose of blunt-end ligation. The reaction was again
heat-inactivated at 75°C for 20 min, and EcoRI was then
added to produce EcoRI sticky ends on the blunt-end ligated
DNA in order to be inserted into the EcoRI site of the
vector (PSK) [81,82].
Meanwhile, the PSK vector was digested by EcoRI,
purified by phenol extraction. To prevent recirculation of
the sticky-ends vector, the DNA solution was 5'-end
dephosphorylated with alkaline phosphatase (CIAP, Promega).
Fine-ground glassmilk (Geneclean protocol, Biol 101)
was utilized to purify the DNAs prepared above. The purified
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hZP3 DNA prepared above, was ligated with the prepared PSK
vector at 4-16°C for 18 hr. The DNA construct (hZP3/PSK) was
transformed into XLl-Blue competent cells, using the Mandel
and Higa method [71] and plated onto X-Gal ampicillinagarose. The white clones were selected and grown in LB
medium with 75 /xg/ml ampicillin at 37°C.
The DNA plasmid (hZP3/PSK) was isolated from the
selected clones by the alkaline-detergent method (mini-prep
method)

[81] and identified by restriction mapping (using

BstXI, MvnI, and Seal restriction enzymes) [40], Southern
blot analysis (using a probe designed to identify an
internal sequence of the cDNA), and PCR (using the same 5'
terminal primer used in previous RT-PCR and the internal
probe used in Southern blot analysis). In addition, in vitro
translation (TNT T3 coupled reticulocyte lysate system,
Promega) using radioactive methionine was carried out to
ensure that a full length protein (non-glycosylated ZP3) is
synthesized by this cDNA of hZP3 as determined by SDS-PAGE
and autoradiography.
In order to express the cDNA of hZP3 in mammalian
cells (human ovarian tumor cell), the cloned cDNA was
subcloned into a mammalian cell expression vector (pREP4).
The plasmid DNA (hZP3/PSK) isolated from the selected clones
was digested with BamHI and Xhol restriction enzymes to
produce sticky ends and then ligated with the episomal
expression vector pREP4 (containing the Rous sarcoma virus
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promotor and hygromycin-resistant gene) with T4 DNA ligase
at 4-16°C for 18 hr. Restriction mapping, Southern blot
analysis and PCR were again performed to select the correct
clones. Approximately, 300 clones were analyzed. Spin column
(Maxiprep, Promega) was used to produce high quality and
large amounts of supercoiled DNA construct for the further
application. Further purification of the cDNA construct was
achieved by alcohol precipitation with the addition of 0.3 M
sodium acetate at -80°C for 4 hr.

6. 5'-end radioactive labelling of oligonucleotide probe

The reaction for the radioactive labelling of the
oligonucleotide probe SI (see Materials) for Southern blot
analysis was performed at 37°C for 10 min by adding 200 ng
of the internal probe (SI) , 70 /xCi of [y-32P]ATP and 10 U of
T4 polynucleotide kinase in 1 x forward exchange buffer (50
mM Tris-HCl, 10.0 mM MgCl,, 0.1 mM spermidineand and 5.0 mM
DTT, pH 7.5) with a final volume of 10.0 /xl. The reaction
was stopped by adding 5.0 /*1 of 0.1 M EDTA. Right before
use, the radioactively labelled SI probe solution was boiled
for 10 min and then chilled on ice.

7. Southern blot analysis

Southern blot analysis was performed to identify the
DNA constructs of the cDNA of hZP3 by using an internal
probe SI [81]. DNAs were run on an agarose gel, then the gel
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was soaked in denaturing solution (1.5 M NaCl, and 0.5 M
NaOH) for 45 min, and then in neutralization solution (1.5 M
NaCl, 1.0 M Tris, pH 7.4) for 30 min. Blot transfer of DNA
fragments to nitrocellulose membrane was performed by
capillary action (simple diffusion method) in 10 x SSC
buffer (1.5 M NaCl, 0.15 M sodium citrate, pH 7.0) for 16 hr
[81]. The blot membrane was air-dried on a 3 MM paper for 30
min, UV cross-linked at 0.12 joules per cm2 of membrane for
1 min, and then prehybridized in a sealable bag with pre
hybridization solution (25.0 mM KI^PO,,, 5 x Denhardt's
solution, 50 ^g/ml salmon sperm DNA, and 50% formamide in 5
x SSC buffer) at 42°C for 3 hr by gentle shaking [81] .
The prehybridization solution was removed from the
sealable bag and the blot membrane was transferred to a new
bag containing the prepared oligonucleotide probe in hybri
dization solution (the same as prehybridization solution but
without the Denhardt's solution). The bag was placed in
water bath at 42°C with gentle shaking for 10 hr. The
membrane was removed and washed in 1 x SSC with 0.1% SDS
twice for 15 min each at room temperature, and then in 0.25
x SSC with 0.1% SDS twice for 15 min each at 42°C. The
membrane was then air-dried on a piece of 3 MM paper,
wrapped in saran wrap and put in a Kodak X-ray holder with
Kodak XAR-5 X-ray film and intensifying screen for an
appropriate duration of time at -70°C.
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8. I n v i t r o transcription/translation

TNT Couple Reticulocyte Lysate system was used to test
the capacity of the cloned hZP3 cDNA to produce a full
length nonglycosylated protein following manufacturer's
instruction. DNA template (2.0 /xg) was added into 25.0

/x1

of

TNT rabbit reticulocyte lysate. Then 2.0 (il of TNT reaction
buffer (Promega) , 1.0 /x1 of T3 RNA polymerase, 1.0 /x1 of
amino acid mixture without methionine, 4.0 jxl of 35Smethionine (1000 Ci/mmol at 10 mCi/ml) , and 40 U of RNasin
(RNase inhibitor) were added into the DNA solution above,
and the final volume was adjusted to 50.0 /xl by RNase-free
water. The reaction was performed at 30°C for 2 hr.
Luciferase DNA was used as a positive control, and the
plasmid with opposite orientation insertion of hZP3 cDNA
into PSK vector was used as a negative control. In order to
analyze the result of translation, a discontinuous SDS-PAGE
was run (with 10% separating gel and 4% stacking gel) , gel
was dried by gel-drier, and autoradiography was performed as
described before.

9. DNA purification by CsCl ultracentrifugation

For the purpose of cell transfection, DNA construct
(hZP3/pREP4) was further purified by ultracentrifugation in
CsCl as follows: One liter of cells incubated overnight was
pelleted at 5000 x g for 5 min and then was resuspended in
30.0 ml of alkaline lysis solution I (50.0 mM of glucose,
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10.0 mM EDTA and 25.0 mM Tris, pH 8.0) by shaking and
vortexing. A 30.0 ml of lysis solution buffer II (0.2 M NaCl
and 1% of SDS) was added, and the mixture was incubated on
ice for exactly 5 min. Then 22.5 ml of 5.0 M potassium
acetate (pH 5.5) was added, and the lysate solution was
incubated on ice for exactly 5 min. Centrifugation was
performed at 10,000 x g for 20 min at 4°C and the super
natant containing DNA was carefully transferred to another
tube. DNA was precipitated at room temperature for 20 min by
adding 1 volume of isopropanol, spun down, air-dried, and
then dissolved in 15.0 ml of TE buffer (1.0 mM EDTA, 10.0 mM
Tris.Cl, pH 7.4).
Purification was achieved by sequential extraction one
time with 1 volume of phenol, once with one volume of
phenol: chloroform: isoamyl alcohol (25:24:1), and one time
with one volume of chloroform: isoamyl alcohol (24:1). DNA
was precipitated at -20°C overnight by adding 2.5 volumes of
100% ethanol and 0.3 M sodium acetate (pH 5.2), spun down,
air-dried, and dissolved in TE buffer again to a final
volume of 17.0 ml. Then 1.9 ml of 5% lauroylsarcosine
solution and 19.6 g CsCl were added and mixed well until
CsCl dissolved completely. After 1.2 ml of 10.0 mg/ml of
ethidium bromide was added, the solution was separated to
two "heat sealable" centrifuge tubes. Balance was corrected
up to 0.1 g. The tubes were capped by heat, and then centri
fugation was performed at 55,000 rpm (26,000 x g) with a
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VTi65 rotor for 16 hr. The supercoiled DNA (the lower band)
was collected through the side of the tube by syringe (with
18 gauge needle) under UV lamp, and was extracted with
water-saturated n-butanol to remove the ethidium bromide
until clear by checking under UV light.
The solution was dialyzed overnight with 2 1 TE buffer
to remove CsCl, and then DNA was precipitated at -20°C
overnight by adding 1/10 volume 3.0 M sodium acetate (pH
5.2)

and 2.5 volume 100% ethanol. The DNA was spun down,

washed with 70% ethanol, air-dried, and then dissolved in
0.5 ml of TE buffer (pH 7.0). The concentration and quality
was measured with A ^ and

spectrophotometrically [81] .

10. Stable transfection

PA-1 cell was stably transfected with the hZP3/pREP4
DNA construct by using calcium phosphate-mediated trans
fection method [81,82] . A 50 /xg/ml of DNA solution was
prepared by adding 62 /*1 of CaCl2 and sterile water to a
final volume of 0.5 ml. The DNA solution was added dropwise
into 0.5 ml of sterile 2 x HBS (280 mM NaCl, 10.0 mM KC1,
1.5 mM Na,HP04.2H,0, 12.0 mM dextrose, and 50.0 mM HEPES, pH
7.05) under a stream of air, and then incubated at room
temperature for 20 min to precipitate DNA. Right before use,
the DNA precipitate was dispersed by vortex gently (speed 4
with a Vortex-Genie (Scientific Industries Inc, NY)) for 10
sec, and the medium was removed from the cells. The calcium
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phosphate-precipitated DNA suspension was transferred
carefully onto the cell monolayer and incubated at room
temperature for 15 min.
Culture medium (MEM with 10% FBS) was then laid gently
onto the cells. The cells were cultured for 18 hr to allow
endocytosis happen, washed twice by PBS, and cultured for
another 24 hr in regular medium.
Selection medium (regular medium with 150 /xg/ml of
hygromycin) was then used for three weeks to established the
stably transfected cells [76,81,84,85], and the selection
medium was changed every 2-3 days.
Cloning ring with 3 mm internal diameter was used to
isolate the viable single colonies [75], and trypsin-EDTA
was used to release cells. Approximately, 150 single
colonies were isolated.
The integration of hZP3/pREP4 DNA into the host
genomic DNA was identified by PCR, the expression of the
cDNA of human ZP3 in the transfected cells was assessed by
RT-PCR and the secretion of recombinant protein was assessed
by ELISA (described later).
When the selected single colonies of transfected cells
reached about 70% confluence in six-wells clusters, the
cells were harvested, resuspended in cryogenic medium (9%
DMSO/FBS), and stored in liquid nitrogen by following
standard protocol.
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11. RT-PCR for the clonal selection of stable-transfected
cells

RT-PCR was performed for the identification of hZP3
cDNA expression in the transfected cells. The cytoplasmic
total RNA was isolated by the method described before,
dissolved in RNase-free water, and stored at -20°C if not
used immediately [83].
In order to select the stably transfected clones from
a large number of candidate clones, total RNA (10 /xg) was
used instead of mRNA in this RT-PCR. The RT reaction was
performed as described before except that 1.5 mM of each
dNTPs (dATP, dTTP, dCTP and dGTP) and 0 .5 /xg BSA were used
to optimize the reaction. In addition, reaction was
performed at 37°C for 1.5 hr, stopped by adding 30 fxl of
sterile water, incubated at 95°C for 5 min and then cooled
on ice immediately.
The RT reaction was followed directly by PCR reaction.
Only 7.5 ^1 of the RT final solution (prepared above) was
used to perform a PCR, the remaining material was stored at
-20°C. The sample used was equivalent to the RT product of
1.5 tig of total RNA.
The PCR was optimized by the following conditions:
Each CH-1 and SI primer (see

Materials) was

amount of 0.15 ixM into 7.5 /x1 of the RT

addedin the

solution. Then 2.0

mM MgCl,, 2 U Taq polymerase,

and 0.1 mM of each dNTPs were

added in 5.0 fxl PCR reaction

buffer and the

finalvolume was
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brought to 50.0 pi with sterile water. The thermocycler was
programmed as follows: 94°C denaturing for 45 sec, 55°C
annealing for 1 min, and then 72°C primer extension for 1
min, for a total 35 cycles of amplification, followed by a
final extension at 72°C for 5 min.

12. Isolation of

genomic DNA

The genomic DNA was isolated by Higuchi's method [86].
The cells were lysed in a alkaline buffer containing non
ionic detergents and Proteinase K. In this method, the RNA
was destroyed by alkaline hydrolysis, and the DNA remained
intact and was used directly in PCR.
A "PCR buffer" (50.0 mM KC1, 0.1 mg/ml gelatin, 0.45%
NP -40, 0.45% Tween 20, 2.5 mM MgCl2 and 10.0 mM Tris, pH
8.3) was prepared, autoclaved and stored frozen. When ready
to use, the buffer was thawed, and 0.6 pi of 10.0 mg/ml
Proteinase K was added per 100 p1 of the solution.
A 40 mm dish of cells were washed with PBS, scrapped
free by rubber policeman, and resuspended in 150 pi of the
prepared buffer (to make a solution of about 6 x 106 cells
per ml). The cell suspension was incubated at 55°C for 1 hr
to lyse the cells,

release chromosomal DNAfrom

histone, and

hydrolyze the RNA.

Then the proteinaseK wasinactivated

at

95°C for 10 min. The lysate was either stored frozen at -20°C
or used directly as sample for PCR. Typically, 25 pi of the
lysate thus prepared was about 1 pg of genomic DNA according
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to Higuchi's estimation [86].

13. PCR for the clonal selection of the stable-transfected
cells

A PCR was performed to verify genomic integration of
the hZP3 cDNA construct in transfected cells.
The conditions for the PCR were optimized as follows:
Two microliters of the lysate mentioned above (which was
about 80 ng of the genomic DNA), 1.0 mM of MgCl2, 0.4 mM of
each dNTPs, 2.5 U of Taq polymerase, and 0.075 [jlM of each
primer (CH-1 and SI primers, see materials) were added in
5.0 fil of 10 x Thermophilic Buffer (500 mM KC1, 100 mM TrisHC1 (pH 9.0), 1% Triton X-100) to a final reaction volume of
50.0 fxl. The other reaction conditions were the same as that
in the "RT-PCR for clonal selection of the transfected
cells" described previously.

14. Protein purification
Purification by WGA-Lectin chromatography

The WGA-coupled particles were equilibrated with PBS
buffer, and then packed into a column (5 cm long with a
diameter of 1.5 cm). The glycoproteins were initially
isolated by WGA-Sepharose chromatography at 4°C. Typically,
150.0 ml of culture medium was collected, and then
concentrated to a final volume of 40.0 ml by centrifugation
4 times at 1500 x g with Centriprep-30 following manu
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facturer's instruction. To protect the protein, proteinase
inhibitors (as mentioned in Medium Collection) and sodium
azide (0.1%) were added before the sample was applied to a
WGA-Sepharose column equilibrated with PBS with 0.1% sodium
azide. After washing with PBS for 4 hr at a flow rate about
5 ml/hr, the absorbed fraction was eluted with 0.5 M Nacetylglucosamine in PBS (87] . In order to remove the
suspended WGA lectin molecules, the eluted solution was
passed through an anti-WGA immunoaffinity column (2 cm long
and 1.5 cm in diameter) packed with anti-WGA immobilized
Sepharose 6B particles. The preparation of the anti-WGA
immunoaffinity chromatography was described as follows.

Preparation of anti-WGA ixnmunoaffinity chromatography

One milligram of antibody was dissolved in 1.5 ml of
coupling buffer (50.0 mM sodium acetate, pH 5.5), purified
and washed three times with coupling buffer by ultra
filtration (Centricone, Amicon). To oxidize the carbohydrate
moieties on IgG, the antibody solution was incubated at room
temperature in the dark for 1 hr by adding One-tenth volume
of NaI04 solution (25.0 mg/1.2 ml) .
The oxidized IgG was purified by Sepharose 10 column
(Econo-Pac 10 DG column, Bio-Rad, 2.0 cm diameter, 5.0 cm
long) as manufacturer's instruction. Right before use, the
column was washed with 20.0 ml of coupling buffer, and then
exactly 3.0 ml of IgG solution was added to the column. The
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column was eluted with coupling buffer. The first 3.0 ml of
eluent was discarded and then 0.5 ml fractions were
collected for 5 ml total elution. The optical absorbance of
every fraction was measured at 280 nm. The first peak
fractions were collected. The Sepharose 10 column was re
generated by at least 20 ml of coupling buffer and stored in
coupling buffer with 0.02% of sodium azide.
After 1.5 ml of "affini-hydrazide gel" (affi-gel Hz,
Bio-Rad) was washed twice with 10 ml of coupling buffer in a
polypropylene tube, the prepared IgG was added directly into
the washed gel and incubation was performed for 10-24 hr at
room temperature by shaking gently.
The IgG-coupled gel particles were packed into a
prepared column (1.0 cm diameter, 10.0 cm long), washed with
1 volume of 0.5 M NaCl/PBS to remove the unbound IgG, and
washed with ten bed-volumes of PBS before usage. For long
term storage, the column was stored in PBS buffer with 0.02%
of sodium azide.

Protein concentration

Centriprep and centricone (with a 30 kDa cut off
range) were used for concentrating the protein solution
before being applied onto the columns. The protein was
concentrated by Centriprep-30 and Centricone-30 to suitable
volume depending on the initial amount of sample used
following manufacturer's instruction. In order to increase
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the efficiency of protein recovery, 3% BSA solution was used
to pre-coat the membrane of the Centriprep-30 by centri
fugation at 1500 x g for 15 min. The pre-coated Centriprep30 was washed thoroughly with PBS twice by centrifugation at
1500 x g for 15 min. For Western blot analysis, the re
combinant glyprotein was isolated by the Centricone-30
without the pre-treatment of BSA to prevent the cross
reaction of suspended BSA with the antibody used. The final
product of the recombinant glycoprotein was approximately
concentrated to 1.0 mg/ml, aliquoted and stored by frozen at
-80°C by adding 6.1% glycerol.

15. Protein assay

BCA protein assay was used to measure the quantity of
the protein content as manufacturer's instruction (Pierce,
Rockford, IL) [88].
BSA were prepared in PBS buffer from 100 /ig/ml to 1200
Hg/ml and used as standards of the protein assay. The
working buffer was prepared as manufacturer's instruction by
mixing fifty parts of reagent A (bicinchoninic acid (BCA)
solution) with one part of reagent B (4% copper sulfate
solution). Each standard or unknown sample was pipetted in
the amount of 25.0 fil into the appropriately labelled test
tube, and PBS was used as a blank control. Then 500 ixl of
working buffer prepared above was added into each tube,
mixed well, covered with Saran wrap, and incubated at 37°C
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for 20 min. After incubation, all tubes were set on the
bench to allow the solution cool down to room temperature.
Exactly 200 fi1 of solution was transferred from each test
tube to microtiter plate. The absorbances at 570 nm were
measured by microtiter plate reader. The concentration of
protein was obtained by the absorbance and the linear
equation of the standard curve.

16. ELISA

For the detection of hZP3 secretion from stably
transfected cells, A rabbit polyclonal antibody (Ab5a)
against a conserved oligopeptide sequence of ZP3 protein
(PIECRYPRQGNVSS) which was amino acids 137-150 deduced from
the DNA sequence among several species (human, mouse, and
hamster) was used in ELISA. This antibody was a kind gift
from Dr. Hinsch and was previously characterized by positive
immunohistochemical staining in human oocytes and by Western
blotting in vitro [45,46].
The production of the antibody was as follows: Five
milligrams of peptide was dissolved in 500 fi1 of distilled
water, added to 10.0 mg of KLH (keyhole limpet hemocyanin),
dissolved in 1.5 ml sodium phosphate buffer, pH 7.0, and
mixed with 0.5 ml of 10.0 mg/ml EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride). The pH was
maintained at about 5.1 for 1 hr. Then an additional 0.5 ml
of 10.0 mg/ml EDC was added, and the mixture was incubated
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for 24 hr at room temperature. The conjugate was dialyzed
against 15 1 of distilled water for 24 hr, lyophilized, and
stored desiccated at -20°C. Female New Zealand rabbits were
inoculated intradermally with 1.0 mg of the conjugate and
antisera were collected. For affinity purification of
antibody, peptide used for immunization was coupled to an
AminoLink affinity column, and performed according to
manufacturer's instruction [45].
Samples and controls were coated to a microtiter plate
(EIA grade, Costar) in 100 jttl aliquots at room temperature
for 9 hr in a humid atmosphere. The microtiter plate was
washed six times with PBS by a 12-channel plate washer (Nunc
well washer, Fisher) to remove the unbound antigen. The
blocking buffer (0.2% Tween 20 in PBS buffer) was added and
incubated for two hours in a humid atmosphere at room
temperature. The plate was washed with PBS buffer, and then
100 fi1 of Ab5a (1:100 dilution in 0.2% Tween 20/PBS) was
added and incubated for 1.5 hr. Horseradish peroxidase
conjugated goat anti-rabbit IgG was used as second Ab (1:200
dilution in 0.2% Tween 20/PBS), and was incubated for one
hour. A 100 fil of tetramethyl-benzidine (TMB, Pierce) was
added to each well, and incubated at room temperature for 5
min for color development. The positive wells appeared pale
blue. The reaction was stopped by adding 120 pi of 1.0 M
H2S04, and the absorbance at 450 nm was measured.
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17. Metabolic labelling experiment

In order to distinguish the biosynthesized
glycoproteins from the endogenous glycoproteins, a 3Hgalactose metabolic labelling experiment was performed [89].
Transfected cells and non-transfected cells were split to
15% confluence in MEM containing 10% FBS. The cells were
cultured for 4 hr until attached to the plate surface, and
then washed by PBS to remove the suspended cell-debris. The
"radioactive" medium containing 250 fiCl of 3H-galactose was
added, and cells was cultured for additional 16 hr. The
medium was collected as described in previous section.
Meanwhile, another portion of 5.0 ml of 3H-galactose medium
was added into the cells for another 12 hr incubation.
The unincorporated 3H-galactose was removed from the
collected medium by Centriprep with a 30 kDa cut-off range
(1500 x g for 30 min). The retentate was washed three more
time with PBS buffer (approximately, a total 40.0 ml of
buffer was used for the washing). Both the retentate and the
residual (washing) solutions were collected for further
study. Another Spin was made to concentrate the retentate.
The final volume was measured, and sodium azide with
protease inhibitors were added immediately. The final
retentate was adjusted to 2.0 ml by PBS. An aliquot of 5.0
jj.1 solution in every samples (the retentate and washing
solutions) was used to measure the radioactivity.
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One million cpm of metabolic solution (retentate) was
passed through a wheat germ agglutinin (WGA) lectin column
prepared as described previously, washed by ten bed volumes
of PBS solution, and eluted by elution buffer (0.5 M Nacetylgalactosamine/PBS solution). Both of the WGA bound,
and non-bound fractions were collected respectively. A
suitable amount (10,000 cpm) of samples were loaded in SDSPAGE gel with 4% stacking and 8% separation layers [81]. The
SDS-PAGE was run with Tris-glycine buffer at 13 mA. The gel
was fixed in 500 ml of methanol:acetic acid:water (25:10:65)
for 30 min, soaked in 200 ml of "enhancer" solution
(Amersham) for 30 min, and then dried by heating under
vacuum for 1 hr. Autoradiography was performed as described
before. In general, it took one week for the gel exposure to
X-ray film at -80°C before development.

18. Silver-staining of SDS-PAGE

SDS-PAGE was prepared with a 10% separating gel and a
4% stacking gel [81]. The protein samples was added by 1
volume of a loading buffer containing 2% SDS, 10% glycerol,
10% beta-mercaptoethanol, 0.001% bromophenol blue and 100 mM
dithiothreitol in 50.0 mM Tris, pH 6.8, was used. After
heating the samples at 100°C for 2 min, electrophoresis was
run with Tris-Glycine buffer (pH 8.3) at 100 volts

until

the dye reached the bottom of the gel [81]. The gel was
incubated at 4°C overnight in fixing solution (40% methanol/
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10% acetic acid), and then in 10% ethanol/5% acetic acid
twice for 30 min each time.
The oxidizer reagent and silver reagent are prepared
according to manufacturer's instruction (Bio-Rad) by
diluting the concentrate solution ten times with deionized
distilled water before use. The Development solution was
also prepared according to manufacturer's instruction.
The gel was oxidized by prepared oxidizer reagent for
10 min with gentle shaking, washed three times with
deionized distilled water for 10 min each time, and then
incubated at room temperature for 30 min with prepared
silver reagent by shaking gently. The gel was washed again
with deionized distilled water for 2 min with gentle
shaking, and then developed by development solution until
the solution turned yellow or until brown smokey precipitate
appeared. The development solution was exchanged for another
fraction of the same solution and incubated at room
temperature by gentle shaking until the desired intensity
was observed. The reaction was stopped by 5% acetic acid
solution. The gel was washed in deionized distilled water
for 10 min before photography.

19. Western blot analysis

SDS-PAGE with a 10% separating gel and a 4% stacking
gel was performed as described previously [81] , using a
minigel system (Hoefer Scientific, San Francisco). Wet
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transfer of protein was performed at 63 volts for 14 hr in
transfer buffer prepared by adding 5.8 g Tris, 1.0 g SDS,
29.0 g Glycine, and 200 ml methanol in 1 1 of water [79].
After transfer, the membrane was blocked with blocking
buffer (0.2% Tween 20 in PBS buffer) for 2 hr by gentle
shaking. The membrane was aligned onto a Deca-probe incu
bation manifold (Hoefer).
Then 1.5 ml of the Ab5a (1:50 dilution in 0.2% Tween
20/PBS) was added and incubated at room temperature for one
hour by shaking gently. The membrane was washed three times
with washing solution (0.2% Tween 20/ PBS) for 5 min each to
remove unbound antibody. A second antibody solution (biotinylated goat anti-rabbit IgG) and "ABC solution" (Avidin
DH and biotinylated alkaline phosphatase H) were prepared in
washing solution as manufacturer's instruction (Vector). The
prepared second antibody solution was poured over membrane
and incubation was continued for 30 min at room temperature
with gentle shaking. The membrane was washed three times
with washing solution for 5 min each to remove unbound
second antibody. The previously prepared "ABC" solution was
then poured over membrane, and incubation was performed with
gentle shaking for 30 min at room temperature.
After another three washes with washing solution, the
membrane was removed from manifold, and rinsed once in
washing solution 2 (0.2% Tween 20, 150 mM NaCl, and 50.0 mM
Tris, pH 7.5), and then soaked in another aliquot of the
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same solution with agitation for 5 min. The membrane was
washed twice with washing solution 3 (150 mM NaCl, 50.0 mM
Tris, pH 7.5) for 2 min. Meanwhile, BCIP/NBT solution was
prepared as manufacturer's instruction (Vector). The immune
complexes were visualized with BCIP/NBT in the dark for 5-30
min until the satisfactory staining intensity depending on
the amount of antigen loaded on the gel. Another Wash for 5
min in water was made before photography. The stained
membrane was dried and stored folded between two pieces of 3
MM filter paper.

20. Hemizona assay

Human immature (prophase I) oocytes were stored in a
hyperosmotic solution consisting of 1.5 M MgCl2 supplemented
with 0.1 % polyvinylpyrrolidone (PVP) in 40 mM Hepes buffer
(pH 7.3). Oocytes prepared in this manner can be stored at
4°C for up to 90 days without loss of activity in the HZA.
Before the assay, the oocytes were removed from storage and
rinsed in Ham's F-10 medium. Narishige micromanipulators
(Tokyo, Japan) mounted on a phase-contrast inverted
microscope (Nikon Diaphot, Garden City, NY) are used for
cutting the oocytes into matching hemizonae. A detailed
protocol for the microbisection procedure and oocyte
handling has been described.
Semen samples were provided by fertile men (donors) by
masturbation after 3-5 days of sexual abstinence. Sperm were
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washed twice by Ham's F10 medium with 3.5% of human serum
albumin (swim-up solution) and centrifuged at 400 x g for
7 min and 5 min respectively. The sperm pellet was overlaid
with 0.5ml of swim-up solution as described above for one
hour at 37°C, and the upper fraction of motile swim-up sperm
was collected for further experiment. The sperm numbers
before and after swim-up procedure were counted for the
preparation of sperm concentration.
For the HZA, two sperm suspensions were prepared: one
was utilized as the control sperm (incubated at 37°C in 5%
C02 in air), while the other one was incubated under
identical conditions but in the presence of the test
substance (hZP3). Different given concentrations of hZP3
were examined (60 min incubation time). After this
incubation period, the sperm was subjected to a wash and
centrifugation step to remove excess protein (control sperm
are treated identically) . A 100 fxl sperm droplet from the
control sperm was placed under previously equilibrated
mineral oil, and incubated with a hemizona for 4 hr at 37°C
in 5% C02 in air. A 100 fxl droplet of the test sperm
suspension was incubated with the matching hemizona (from
the same pair) under identical conditions. Following the 4
hr incubation period, the hemizonae were rinsed in culture
medium using a finely drawn glass pipette in order to
dislodge loosely attached sperm. Thereafter, the number of
spermatozoa tightly bound to the outer (convex) surface of
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each hemizona was counted employing phase-contrast
microscopy (x 200) . For each assay, the HZA results were
expressed as hemizona index (HZI) calculated as follows:
numbers of sperm bound for test/control x 100.
Typically, the control sperm suspension was incubated
in culture medium while the test sperm suspension was
incubated with hZP3. Experiments were also carried out
assaying control sperm (in Ham's F-10) versus test sperm
exposed to the different cell transfection and protein
separation conditions including: culture medium of non
transfected cells and WGA non-bound fraction from the
protein separation procedures. For each given condition
tested in the HZA, 5-8 oocytes were used and binding results
statistically analyzed by a paired t-test [90-107] .

21. Acrosome reaction assay

The acrosomal status of spermatozoa was evaluated
using the fluorescent probe fluorescein isothiocyanatelabeled Pisum Sativum agglutinin (FITC-PSA) following
previously described techniques. Assay slides were read
using an epifluorescent microscope at 400 x magnification;
duplicate slides were evaluated for each treatment and time
analyzed, assessed blindly by two different experienced
observers and results averaged. At least 100 cells were
evaluated per slide. Acrosome reacted sperm were diagnosed
when a total loss of the acrosomal cap was observed (bar
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pattern), or no immunofluorescence was seen at all.
Acrosome-intact sperm typically show staining of the entire
acrosomal cap [29-35,108].
The acrosomal status of control and test (rZP3treated) sperm was initially examined under basal conditions
(spontaneous acrosome reaction). Different concentrations of
rZP3 were assessed. In addition, sperm motility was
evaluated by the aid of a semen computer analyzer (HamiltonThorn, Beverly, MA).

22) Statistical analysis

The results of the Hemizona assay (test versus
control) were analyzed by paired t-test by the aid of
computer (CSS, Statistica). The formula for paired t-test is
as follows:
t=

Where Sj and s2 are the standard deviations of the test
and control groups respectively,and n, and n2 are the number
of samples in test and control groups respectively.

(X,-X2)

represents the difference between the means of the two
groups. The term (/z,-/z2) is based upon the null hypothesis,
which assumes that the two populations are not different and
therefore the difference is equal to zero. So (/Z]-/x2) = 0.
The term r is the correlation coefficient, and the
formula is as follows:
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(2X)(2Y)
IXY-- £— -

Where X and Y represents the score in test and control
group respectively, and n is the number of pairs of scores.
The results of the paired t-test were scored by the t
and p values. The larger the t score is and the smaller the
p score is, the more significant the results are [103,109].
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IV. Results

A. Subcloning of the full-length cDNA of human ZP3

Dean reported that in the mouse, the expression of
hZP3 protein is highly restricted to the growing oocyte
[39,40]. We obtained total RNA from fresh, surgically
removed human ovary using Chirwin's guanidinium thiocyanate
extraction method [80]. The result of the extraction was
confirmed by the observation of the sharp bands of the 28 S
and 18 S rRNAs that

appeared on agarose gel. This was

followed by isolation of polyadenylated mRNA by using the
biotin-labeled oligo(dT) and avidin-bound polymagnetic
particle method.
A pair of primers (CH-1 and CH-2 primers) was designed
based on the reported sequence of hZP3 [40] . Results of the
restriction digestion and the length of produced cDNA from
the RT-PCR are shown in Fig 3. The full length and the
restriction digestion fragments of the RT-PCR product are
exactly as expected [40], suggesting that the RT-PCR product
may be a full length cDNA of hZP3 and that the amplification
is completely specific because there was only one single
band found. In order to further identify the RT-PCR product,
a 21 bases internal probe (SI primer) was designed to
58
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Fig 3. Restriction digestion analysis of the RT/PCR product.
(A) After mRNA was isolated from the ovary, RT-PCR was
performed and the product (cDNA) was identified by
restriction mapping. The produced RT/PCR product is
probably the full length cDNA of hZP3 (1278 bp)
estimated according to the 123 DNA marker (ladder) based
on that difference between every band in the marker is
123 base-pairs. In addition, three restriction enzymes
were used: Seal, BstXI, and MvnI. The restriction
mapping was matched with hZP3 as expected. The 401 bp
band in MvnI digestion; 156 bp and 142 bp bands in
BstXI; 51 bp band in Seal can not be seen in this figure
due to low intensity.
(B) Scheme for the restriction digestion.
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specifically recognize the cDNA of human ZP3 [40,65]. This
probe was labelled with 32P-ATP and hybridized to the intact
cDNA and its restriction digested fragments, and visualized
by autoradiography (Fig 4). The results of Southern blot
analysis were exactly as expected. The RT-PCR product (cDNA
solution) was directly purified by phenol extraction and
stored at 4°C.
For further application, the purified RT-PCR product
(hZP3 cDNA) was inserted into the PSK (pBluescript SK)
vector, and then the hZP3/PSK construct was introduced into
XL-l Ecoli [7,71] . Approximately 100 clones were selected by
color selection as described in the Methods. DNA was
extracted from each individual clone of the positive ones,
and further selection and identification were fulfilled by
restriction mapping, Southern blot analysis and PCR using an
internal probe (SI primer)(Fig 5 and Fig 6). Seven clones
demonstrated expected pattern of restriction digestion and
Southern blot analysis (Fig 5) .
Polymerase chain reaction (PCR) was performed to
further identify the selected clones by using two pairs of
primers (CH-l/CH-2 and CH-1/S1) as shown in Fig 6. The
results demonstrated single band amplification at the
expected sites by CH-l/CH-2 and CH-1/S1 primers (Fig 6).
Both linear and circular DNAs from selected transformed
clones (hZP3/PSK DNA construct) were used to identify the
correct insertion of the cDNA of hZP3 into the PSK vector.
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Fig 4. Southern blot analysis of the RT-PCR product.
(A) Restriction digestion analysis of the RT-PCR product
(left), and Southern blot analysis by an internal probe
SI (see materials) (right). The same three restriction
enzymes were used: BstXI, Seal, and Sail. The
restriction mapping was matched with the cDNA of hZP3 as
expected, and the Southern blot analysis demonstrated
the hybridizations at the right sites further identified
the RT-PCR product as cDNA of hZP3.
(B) Scheme and results for the restriction digestion and
Southern blot analysis.
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Fig 5. Identification of the hZP3/PSK construct byrestriction digestion and Southern blot analysis.
(A): Restriction digestion analysis of the hZP3/PSK DNA
construct. EcoRI, Smal, Sail, and BamHI/XhoI were used
for the restriction digestion.
(B): Southern blot analysis of the same gel by using an
internal probe (SI).
(C): Scheme for the restriction digestion of hZP3/PSK
construct.
The cDNA of hZP3 (RT-PCR product) which was blunt-end
ligated with EcoRI linkers, was inserted into PSK
vector for the purposes of clone selection, amplifi
cation, long-time storage, and further identification.
The ligated product of the hZP3/PSK construct was
transformed into XL-1 bacteria; clone selection was
made on the agarose plate by color selection and
restriction mapping analysis of the isolated plasmid
DNA (hZP3/PSK construct) was performed.
The scheme for the restriction digestion analysis of
the isolated plasmid DNA of hZP3/PSK construct and the
expected results of the restriction digestion and
Southern blot analysis were shown.
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Fig 6. PCR of the cDNA of hZP3 by an internal probe SI.
(A) DNAs from selected transformed clones (hZP3/PSK DNA
construct) were used to identify the correct insertion
of the cDNA of hZP3 into the PSK vector. Two pairs of
primers were used for this identification : CH-l/CH-2,
and CH-1/S1. A specific amplification of a 1278 basepairs product by using CH-1 and CH-2 primers, and a 954
base-pairs product by using CH-l and SI primers were
observed.
(B) Schemes for the PCR method: the identification of the
insertion of the hZP3 cDNA into the PSK expression
vector.
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The linear DNA was produced by restriction digestion and
purified by the gene-clean glassmilk method.
To further verify the cloned cDNA as hZP3 cDNA,
autosequencing was performed by taking advantage of the T3
and T7 promoters inherent in the PSK vector [110] and the
sequence obtained was compared with the sequence published
by Dean (Appendix I).
Based on the computer print-out, a total of 289 bases
was identified from the 3'-end of hZP3 cDNA by taking
advantage of the T3 promoter and a more than 98% homology
was found with the sequence of hZP3 cDNA reported by Dean
(Fig 7 and Appendix III). A gap was found (base 196-186) and
mis-matched bases were located at the following positions:
331, 314, 310, 284, 289 and 262. However, the sequence under
the big T peak of the gap was found identical to the
published sequence except base 186 and base 196. An extra T
base (base 196) was read mistakenly by the sequencer due to
the large T signal (Appendix III). The mis-matched bases at
position 331, 284, 289 and 262 were found to be machine
error. The sequencer did not recognize the right bases
because the peaks fell just outside the window of detection
set by the technician. The other extra bases obtained (base
363, 353, 349, 345, 298 and 290) were found to be read
mistakenly due to low intensity of signals. The deletion at
base 84 was definitely a machine error because it was
located right inside the sequence of CH-2 primer used for
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Fig 7. Comparison of the sequence of hZP3 cDNA from the 3'end sequencing.
(A): 3'-end sequence of our cloned hZP3 cDNA. The numbers
labelled are according to the print-out result of
autosequencing for the convenience of comparison (see
also Appendix III).
(B) : 3'-end sequence of the hZP3 cDNA published by J.Dean.
The numbers labelled are according to the published
sequence (See also Appendix I).
(C): Scheme for the 3 '-end autosequencing of cDNA of hZP3.
The cDNA of hZP3 (RT-PCR product) inserted into the PSK
vector was further identified by DNA sequencing. DNA
sequencing was achieved from 3'-end of the cDNA of hZP3
by using T3 primer.
Two hundred eighty nine bases of hZP3 cDNA were identified,
and a more than 98% homology with Dean's published sequence
was found. A gap located from base 196-186 was underlined by
dashed periods. The matched bases were represented by large
letters, and the mis-matched ones were represented by small
letters. The mis-matched bases were located at the following
positions: 331,314,310,284 and 262 (according to the print
out result of autosequencing).
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PCR (see Appendix I and Materials).
By taking advantage of the T7 promoter, 224 bases were
identified from the 5'-end of hZP3 cDNA and a more than 91%
homology was found with the sequence published by Dean (Fig
8 and Appendix IV). A 15 bases gap was found (base 182-196),
and the sequence under the big T peak of the gap was found
identical to the published sequence except base 191, 192 and
193. In addition, two extra T bases were read mistakenly by
the sequencer due to the large T signal (Appendix IV). Due
to the low intensity of signals, the mis-matched bases after
the position 228 (11 bases in a total of 15 bases) may be
due to machine error as mentioned above. The other extra
bases obtained (base 255, 261, 266, 279 and 286) were read
mistakenly by the same reason.
In order to express the cloned hZP3 cDNA in PA-1 cell,
the cDNA was subcloned into a mammalian expression vector
(pREP4). The pREP4 vector is mainly composed of a Rous
sarcoma virus long terminal repeat (RSV LTR) as upstream
promoter, Epstein Barr virus OriP element (EBV OriP), EBNA-1
gene, SV40 poly A element and the hygromycin resistance gene
[81]. Restriction mapping and Southern blot analysis were
again performed to identify the correct clones of human ZP3
cDNA (Fig 9). Due to the non-specific digestion of EcoRI
("star" activity), an extra fragment of 400 bp appeared in
the restriction mapping. By using an internal probe (SI),
the Southern blot analysis demonstrated that this non-
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Fig 8. Comparison of the sequence of hZP3 cDNA from the 5'end sequencing.
(A): 5'-end sequence of our cloned hZP3 cDNA. The numbers
labelled are according to the print-out result of
autosequencing for the convenience of comparison (see
also Appendix IV).
(B) : 5'-end sequence of the hZP3 cDNA published by Dean. The
numbers labelled are according to the published
sequence (see also Appendix I).
(C) : Scheme for the 5'-end autosequencing of cDNA of hZP3.
The cDNA of hZP3 (RT-PCR product) inserted into the PSK
vector was further identified by DNA sequencing. DNA
sequencing was achieved from 5'-end of the cDNA of hZP3
by using T7 primer.
Two hundred twenty four bases of hZP3 cDNA were identified
and a more than 91% homology with Dean's published sequence
was found. A gap located from base 182 to 196 was underlined
by dashed periods. The matched bases were represented by
large letters, and the mis-matched ones were represented by
small letters. The different bases (mis-matched ones) were
located at the following positions: 170, 173, 201, 208, 228,
231, 238, 246, 247, 249, 250, 259, 260, 270 and 293
(according to the print-out result of autosequencing).
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Fig 9. Restriction digestion and Southern blot analysis of
the hZP3/pREP4 construct.
(A) Left: Restriction digestion analysis of the hZP3/pREP4
DNA construct. RI, Rl/Scal, and Rl/Sall were used for
the restriction digestion. Rl/Scal digestion was
performed with two restriction enzymes: RI and Seal ;
Rl/Sall digestion was performed with RI and Sail.
(A) Right: the Southern blot analysis of the same gel with
an internal probe SI.
(B):Scheme for the restriction digestion analysis of the
hZP3/ pREP4 construct.
The hZP3/PSK DNA construct was amplified in bacterial
cells, isolated by guanidine thiocyanate method and
purified by the maxi-prep method (spin column, Promega) ,then it was ligated into a mammalian expression vector
(pREP4) at the restriction cutting sites BamHI and Xhol.
SI* which represents the radioactive-labelled internal
prob SI is also shown in this figure.
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specific cutting site was located inside the pREP4 vector,
because a 1278 bp fragment resulted from the cDNA of hZP3
was the only one band hybridized.
Therefore, by using five different identification
criteria based on length of the produced RT-PCR product,
restriction mapping, Southern blot analysis, autosequencing
and PCR, we have convincing evidence that the cDNA of human
ZP3 was correctly amplified by our designed RT-PCR protocol
and cloned into the PSK and pREP4 expression vectors.

B. I n v i t r o transcription/translation

In vitro transcription/translation was performed to
ensure the capacity of the cloned cDNA for producing a full
length non-glycosylated hZP3 product. The TNT Coupled
Reticulocyte Lysate System used bypass many steps in the
standard rabbit reticulocyte lysate translation process by
incorporating transcription directly in the translation mix.
The sequence between the open reading frame of the
cDNA of hZP3 and the T3 promoter of the hZP3/PSK DNA
construct had been checked and no additional translation
starting site (i.e. ATG) found.
A hZP3/PSK DNA construct with the correct orientation
insertion of hZP3 (5'-> 3',see Fig 10) was used as the test
sample for in vitro transcription/translation. According to
the manufacturer's instruction, 35S-methionine was used with
the TNT Lysates for the purpose of autoradiography. A 47 kDa
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Fig 10. In vitro transcription/translation of the hZP3
(nonglycosylated) protein.
(A) An 47 kDa protein was produced in the reticulocyte
lysate system by taking advantage of the T3 promoter
inherently present in the PSK vector. T3 RNA polymerase
was added for the transcription of the inserted DNA.
[35S] -methionine was substituted in the reaction for the
later autoradiography. In addition, Luciferase cDNA was
used as a positive control, and the hZP3/PSK construct
with the opposite orientation of insertion of the cDNA
of hZP3 was used as a negative control.
(B) The protein marker was cut off from the gel and stained
with Coomassie brilliant blue.
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product was produced by the cloned cDNA of hZP3 with 5'-> 3'
orientation insertion. However, the DNA construct with the
opposite orientation insertion (3'-> 5') was used as a
negative control and nothing was found by the same appli
cation. In addition, luciferase cDNA was used as a positive
control according to manufacturer's instruction (Fig 10).
This result indicated that a full-length
nonglycosylated hZP3 (47 kDa) was produced in the TNT Lysate
reaction (transcription and translation) by using the cloned
cDNA construct as template, and there was no reading frame
shift because of the point mutation in the sequence of the
cloned cDNA. Another protein which may be due to the non
completed transcription or translation reaction was also
observed with the molecular mass at about 40 kDa (Fig 10).

C. Stable transfection

A stable transfected human ovarian cell line was
established by the CaP04-mediated transfection method
[77,78,81,111], followed by antibiotic selection (hygromycin) for three weeks [76,84,85]. Since the quality of the
DNA used and the particle size of the DNA produced by CaP04
precipitation were critical for the efficiency of the
introduction of the DNA construct into the host cells by
phagocytosis [81], the supercoiled hZP3/pREP4 DNA construct
was purified by CsCl gradient ultracentrifugation as
described previously. Approximately, 200 single colonies
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were isolated by cloning rings [75].
PCR was used to identify the integration of the
inserted cDNA of hZP3 into the genomic DNA by using CH-1
primer and an internal primer (SI) (Fig 11) . In order to
quickly isolate genomic DNA from a large number of clones,
Higuchi's method was used as described in the Methods [86] .
The transfected cell clones demonstrated a very strong
specifically amplified product at the expected position
(954 bp) on the gel, but not in the non-transfected cells as
well as the cells transfected by vector only (pREP4 only,
without cDNA of hZP3) . A total number of 12 clones were
identified as transfected cells by this method. The high
background resulted from (1) the complexity of genomic DNA
in the host cell, (2) the inherent hZP3 gene in the PA-1
cell (Appendix VIII) , and (3) the PCR conditions used. By
Higuchi's method, the individual genomic DNA was isolated
conveniently from a huge number of clones and the cell
lysates with a lot of impurity were used directly as samples
for PCR. Therefore, the conditions for PCR were not
optimized and resulted in high background.
After knowing that the hZP3 cDNA was integrated into
the genomic DNA in the transfected cells, the RT-PCR was
performed to further identify the expression of the inserted
cDNA by using the same pair of primers (CH-1/S1 primers) . As
can be seen in the Fig 12, only the transfected cells were
found to show distinct specifically amplified product. The
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Fig 11. Identification of the insertion of hZP3 cDNA into
the transfected PA-1 cells by PCR.
Identification of the introduction of hZP3 cDNA into the
genomic DNA of the host cell, PA-1, from the selected stable
transfected cell clones, SKC-P3-15, SKC-P3-23, SKC-P3-19,
and SKC-P3-12 by using CH-1 and an internal primer SI as
shown at the bottom of the figure. A 954 base-pairs of
specific amplification was observed in the transfected
cells. The non-transfected cell and transfected cell with
vector only were used as negative controls. The background
bands were thought to be due to the high complexity of the
genomic DNA, the endogenous hZP3 gene, and mostly the non
optimized PCR conditions (see also Fig 15).

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

73

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Fig 12. Identification of the expression of hZP3 mRNA from
the stable-transfected cell clones by RT-PCR.
The RT-PCR results of the stable transfected cell clones,
SKC-P3-12, and SKC-P3-19 by using the same pair of CH-1
primer and an internal primer SI as shown at the bottom of
the figure. A 954 base-pair product was observed from the
transfected cells, but not in the cells transfected with
vector only. In addition, RNA sample without being
transcribed by RT reaction was also performed by PCR as
another negative control.
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cells transfected by vector only (pREP4, without insertion
of cDNA of hZP3) did not show any RT-PCR product (Fig 12) .
This result indicated that the hZP3 cDNA was expressed in
the transfected cells, and little or no hZP3 mRNA was
detected in the cells transfected with vector only.
In order to identify the production and secretion of
recombinant ZP3 protein in the transfected cells, ELISA was
performed as described in the Methods. The polyclonal anti
body (Ab5a) used for ELISA was produced against a conserved
oligopeptide (epitope) of ZP3 protein among several species
(human, mouse, and hamster)

[45] . This antibody was

previously proven to be effective for the recognition of
human zona pellucida proteins (ZP3, specifically) in
immunohistochemical studies and in Western blot analysis
[45,46]. As shown in Table 1, the results of ELISA
demonstrated the present of hZP3 protein secreted in the
culture medium of transfected cells compared to that of the
cells transfected with vector only (negative control). The
same oligopeptide which was used to produced the antibody
was coated on microtiter wells as a positive control. Two of
the transfected cells (SKC-P3-12 and SKC-P3-19) that showed
the highest absorbance at 540 nm by ELISA were chosen for
further application.
After several experiments, the background of the ELISA
by using the Ab5a was high (Table 1), implying there were
cross-reaction of this antibody with proteins other than

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

Table 1. Identification of protein secretion of the stabletransfected cell clones by ELISA.
A polyclonal antibody (Ab5a) which was produced against a
conserved oligopeptide epitope of hZP3 was used to monitor
the secretion of hZP3 protein in the culture medium. The
original oligopeptide (see Methods) was used as positive
control; and the culture medium from cells transfected by
vector only was used as a negative control. The average
value of four absorbance reading at 540 nm in every sample
was shown in the Table. The high background reading of the
negative control implies the possibility of cross-reactivity
of the polyclonal antibody with proteins other than hZP3.
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hZP3. Therefore, various blocking buffers including BSA,
Superblock (Pierce), Blotto, and Tween 20 in PBS buffer were
tested (data not shown). The cross-reactivity of Ab5a was
found to be strong when BSA and Superblock were used, and
moderate when Blotto was used. The non-protein reagent,
Tween 20 (0.2% in PBS buffer) was finally determined to be
most useful for the blocking process in the Western blot
analysis.

D. Isolation and identification of the recombinant hZP3

For the purpose of the recombinant hZP3 production,
two of the stable transfected cell clones (SKC-P3-12 and
SKC-P3-19) which demonstrated the largest amount of hZP3
secretion by ELISA were cultured and the culture medium was
collected as described in Methods. Size-exclusion chroma
tography (Sepharose-6B) and Lectin chromatography were
performed to isolate the recombinant hZP3 in the culture
medium. After several experiments, WGA was found to be more
specific to hZP3 than Con A (Data not shown), and then sizeexclusion chromatography was performed and found not
effective due to the close molecular weight of the eluted
glycoproteins.
WGA-Sepharose chromatography was finally determined to
be used to isolate the recombinant hZP3 glycoprotein for the
further applications. After the sample was applied to the
WGA-Sepharose column and incubated at 4HC overnight, PBS
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buffer was used to wash the unbound molecules away and then
N-acetyl glucosamine was used as a competitor to the WGAparticle in the Lectin column to elute the bound fraction as
shown in Fig 13. In addition, to prevent the influence of
residual lectin molecules with the bio-assay, the anti-WGA
immunoaffinity chromatography was followed to remove the
suspended WGA molecules in the eluted fraction. The final
product was concentrated and stored as described before.
Typically, an approximate 3 mg of total glycoprotein was
isolated from 150 ml of the culture medium. SDS-PAGE and
Western blot analysis were performed to identify the re
combinant hZP3 protein in the WGA-purified glycoprotein
solution. First of all, proteins were separated by SDS-PAGE
and silver-stained as described in Methods and the results
were shown in Fig 14. Five solubilized zonae pellucidae
(from human oocytes) were also loaded on the gel and the
silver staining demonstrated a strong wide band at about 65
kDa, suggesting the molecular mass of hZP3 may be 65 kDa.
Both the cells which are not transfected and the transfected
cells indicated the major band at the same molecular weight,
suggesting that there were proteins other than hZP3 with the
similar molecular weight in the non-transfected medium. In
addition, the 65 kDa band in the non-transfected medium was
stronger than that in the transfected medium because of the
following two reasons. First, more bands were observed in
the transfected medium (Fig 14) , indicating more kinds of
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Fig 13. Isolation of the recombinant hZP3 glycoprotein by
WGA-Sepharose chromatography.
Culture medium was collected and concentrated by Centriprep30 as described in Methods. The concentrated solution was
applied to the WGA-Sepharose column, PBS was used to wash
the WGA-absorbed glycoproteins and then 0.5 M N-acetylglucosamine was used to elute the WGA-absorbed glycoprotein.
(1): WGA-unbound fraction (washed out by PBS)
(2) : Starting point for the N-acetylglucosamine elution
(3) : Peak of the WGA-absorbed fraction (WGA-purified
glycoproteins)
(4): Basal reading of the elution solution
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Fig 14. Separation of the recombinant hZP3 protein by SDSPAGE.
Left: 50 ng of WGA-absorbed glycoproteins from non-transfected cells and transfected cells were loaded onto a
denaturing SDS-PAGE gel.
Right:Solubilized proteins from five human zonae were used
for the identification of the molecular weight of the
hZP3. Silver stain was performed for the purpose of
visualization.
Both the transfected cells and non-transfected cells have
the stained band at 65 kDa. Distinct bands between WGApurified glycoproteins of transfected and non-transfected
cells were observed, implying distinct glycoproteins were
produced and secreted by the transfected cells.
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proteins were produced by transfected cells and therefore
the intensity of each individual band was decreased. Second,
in order to increase the recovery of glycoprotein, the
Centriprep-30 used for the concentration was pre-coated with
BSA solution. Therefore, there may be somehow more con
tamination of residual BSA in the non-transfected medium
from this process.
Since the silver-staining can not specifically
identify hZP3 from the other proteins with the similar
molecular weight, Western blot analysis was performed. As
shown in Fig 15, the Western blot analysis with polyclonal
antibody Ab5a (as mentioned in Methods), verified the band
at 65 kDa

as the recombinant hZP3. In addition, a second

band hybridized at 100 kDa (or heavier) was also found by
the Western blot analysis in the transfected culture medium.
This suggested the possibility of heterogenous glycosylation
of hZP3 protein in the transfected tumor PA-1 cells [45,46,
77,78,111]. This will be discussed further in the later
chapter. The solubilized zona pellucida was found hybridized
at exactly the same position around 65 kDa '(Fig 15).
In order to identify the newly biosynthesized and
secreted glycoproteins, a metabolic labelling study was
performed by substituting [6-3H]-galactose in the culture
medium of transfected cells and non-transfected cells as
described in the Methods. The reasons for choosing this
monosaccharide were: (1) Galactose is one of the major
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Fig 15. Identification of the secretion of the recombinant
hZP3 protein by Western blot analysis.
One microgram of WGA-purified glycoproteins from nontransfected cells and transfected cells, and solubilized
proteins from five human zonae were loaded onto SDS-PAGE.
And a polyclonal antiserum against a conserved oligopeptide
of ZP3 protein was used for the identification of hZP3.
Distinct bands were found at 65 kDa and 100 kDa from
transfected cells, and the solubilized human zonae proteins
demonstrated a major band around 65 kDa.
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components (estimated at least more than 25%) of the complex
type N-linked and O-linked oligosaccharides which are
believed to be the major types of oligosaccharides in the
hZP3 glycoprotein.

[39,40,49,66-68,112-116]; and (2) there

is less sugar conversion of galactose to other mono
saccharides in vivo [89] .
The culture medium was collected and ultrafiltration
was performed to remove the suspended 3H-galactose in the
medium and PBS was used for the washing (totally, 40.0 ml
were used). The final samples were concentrated to
approximately 2.0 ml by Centricon 30 (Amicon). An aliquot of
5.0 /il solution was taken from the retentates and washing
solutions of both transfected cells and non-transfected
cells to be monitored for radioactivity. The results are
shown in Table 2. According to these results, the glyco
proteins produced and secreted in the transfected cells were
estimated 3.29 times higher than that in the non-transfected
cells from the total radioactivity shown in the retentate
solutions (Table 2) . Most of the 3H-galactose was left
inside the cells (estimated more than 90% of the total 3HGalactose used). Ten more million cpm of radioactivity was
found in the washed solution (suspended 3H-galactose) of the
non-transfected cells than that in the transfected cells,
implying that there was ten more million cpm of radio
activity left inside the transfected cells than that left
inside the non-transfected cells. This also implied that
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Table 2. Summary of metabolic labelling experiment.
3H-galactose was substituted into the culture medium of the
transfected and non-transfected cells to study the
biosynthesized glycoprotein. The culture media from nontransfected cells and transfected cells were centrifuged to
remove the suspending cells, concentrated by Centriprep
ultra-filtration with a 30 kDa cut-off, and washed by 40 ml
of sterile PBS (total volume) to remove the remaining 3Hgalactose in the medium. Five microliter of each sample was
taken for the measurement of the radioactivity, and the
results are shown in the table. The biosynthesized
glycoprotein of the transfected cells was 3.29 times more
than that of the non-transfected cells based on this
calculation.
About 90% of the radioactivity was still left inside the
cells. Less total radioactivity was found in retentate and
washed solution of the transfected cells than that of the
non-transfected cells implied that there were larger amount
of processing glycoproteins insides the transfected cells
than that in the non-transfected cells.
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variety
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average
cpm
N=4

total

total

volume

cpm

transfected

retentate

8472 .2

2 ml

cell

washed

3449 .3

40 ml

27.59 x 10°

retentate

2562.0

2 ml

1.03 x 106

washed

4934.5

40 ml

39.47 x 10b

non-transfected
cell

3.39 x 106

* Glycoprotein in transfected cell = 3.29 x Glycoprotein in
non-transfected cell (after WGA isolation)
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there were still biosynthesized glycoproteins left inside
the transfected cells (not secreted yet).
After the glycoproteins were purified by WGA-Sepharose
chromatography from the culture medium of transfected cells
and non-transfected cells, SDS-PAGE and fluorography were
performed as described previously. As shown in Fig 16,
distinct broad bands were found in the transfected medium at
55-70 kDa (at least three bandings), 80 kDa, and 100 kDa
(Fig 16) . Furthermore, on the same gel, the WGA-unbound
fraction of protein solution (washed solution) from the
culture medium of the transfected cells was also loaded, and
most of the proteins were found at around 50 kDa and 80 kDa.

E. Biological activity of the recombinant hZP3

Sperm motility was examined by the assistance of a
semen computer analyzer and no difference was found between
test and control groups, implying that the WGA-purified
recombinant protein solution did not have toxic effects on
the sperm cells (Data see Appendix V).
The hemizona assay (HZA) was performed to characterize
the biological activity of WGA-purified recombinant protein
and the data were analyzed by a paired t-test (see also
Appendix VI), and the results are shown in Fig 17. When WGApurified culture medium of transfected cells (1:4 dilution,
estimated 2.5 (ig/ml of rZP3) was tested against culture
medium (Ham's F-10), a 49% inhibition in binding was
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Fig 16. Results of metabolic labelling experiment.
3H-Galactose was substituted into the culture medium of the
transfected and non-transfected cells to study the
biosynthesized glycoproteins. The culture media from nontransfected cells and transfected cells were concentrated by
Centriprep ultrafiltration with 30 kDa cut-off; the samples
were purified by passing through WGA-Lectin affinity
chromatography. Distinct bands were demonstrated at 55-70
kDa (three bands), 80 kDa, and 100 kDa. In addition, the
WGA-unbound fraction (washed solution) of the transfected
medium was also loaded on the gel as reference.
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Fig 17. Characterization of the biological activity (spermbinding) of the recombinant glycoprotein in the hemizona
assay (HZA).
Paired t-test was applied to analyze the results of HZA.
WGA-purified culture medium of transfected cells at (1:4
dilution) and (1:8 dilution) were tested by the hemizona
assay, and showed 49% inhibition (n=6, p<0.05) in binding
with (1:4 dilution) sample, but no significant difference
was observed with (1:8 dilution) sample.
Ham's F-10 and WGA-purified culture medium of nontransfected cells were used as negative controls.
The concentrations of total glycoproteins in WGA-purified
culture medium of transfected cells and non-transfected
cells were controlled at 1 mg/ml.
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significantly different
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observed and the results were statistically significant
(n=6, p<0.05 by paired t-test)

(Appendix VI). No significant

differences were observed at a 1:8 dilution. This result
demonstrated that there seems to be a concentrationdependent effect of the recombinant hZP3 in the HZA. In
addition, the WGA-purified culture medium of non-transfected
cells (both 1:4 and 1:8 dilution) did not show any
inhibition (negative control)

(Fig 17).

Furthermore, at a 1:4 dilution, the WGA-purified
culture medium of transfected cells (rhZP3) produced a >50%
induction of acrosome reaction (AR) after overnight
incubation. Both Ham's F-10 and WGA-purified culture medium
of non-transfected cells were used as negative controls
(spontaneous AR). No difference was observed between the
controls (20% basal AR were found) . A 10.0 /tM of calcium
ionophore (A23187) was used as a positive control at the
same conditions, and showed a similar effect to that
achieved with a 1:4 dilution of WGA-purified transfected
cells culture medium (about 70% AR were found).
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V . D ISC U SSIO N AND CO N CLU SIO N S
Recent studies report ZP3 to be critical for the
initiation of fertilization in the mouse model [9,39,117120] . More studies on the human ZP3 protein need to be
performed to prove relevance in the human system. However,
it is difficult to study hZP3 due to: (a) the difficulties
in obtaining enough material for research, and (b) the
heterogeneity of glycosylation of its polypeptide backbone,
which results in difficulty isolating the protein [40,42,
53] . Here we produce the hZP3 cDNA by RT-PCR and express the
hZP3 glycoprotein in stable-transfected PA-1 cells by using
molecular biology techniques, and taking advantage of the
published sequence for hZP3 cDNA [40] .

A. Subcloning of hZP3 cDNA

In the mouse model, the expression of ZP3 is highly
oocyte-specific and is restricted to the 2-weeks growth
phase of oogenesis that occurs prior to ovulation [56,57,
60] . Therefore a fresh, surgically removed human ovary was
used as source of the mRNA for the production of full-length
hZP3 cDNA by RT-PCR. A single product was amplified by RTPCR (Fig 3). The RT-PCR product was identified to be full
length hZP3 cDNA by restriction mapping (Fig 3) , Southern
89
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blot analysis (Fig 4) , and PCR (Data not shown). Further
studies indicated that it is indeed hZP3 cDNA and there is
no reading frame shift, although there may be some point
mutations in the sequence (Figs 7, 8 and 10).
The RT-PCR product (hZP3 cDNA) was first inserted into
pBluescript SK (PSK) vector and then subcloned into an
mammalian expression vector (pREP4). A subcloning strategy
and methodology was developed based on blunt-end ligation
with an oligonucleotide linker, and has been proven to be
effective for the introduction of the RT-PCR products into
vectors. There were many advantages to insert the cDNA into
PSK vector as follows: (1) An in vitro transcription/
translation (by taking advantage of the T3 promoter inherent
in the PSK vector) was performed to identify the capacity of
the cloned cDNA to produce a full-length non-glycosylated
hZP3 protein (47 kDa. Fig 10) . (2) Autosequening was
performed by taking advantage of the T3 and T7 promoters
inherent in the PSK vector (Fig 7, 8; Appendices III, IV) .
(3) "Color selection" using the PSK vector and XLl-Blue
Ecoli bacterial system enhanced the efficiency of clone
selection. Restriction mapping, Southern blot analysis and
PCR were performed to identify the right clone (Figs 5, 6).
In order to express the hZP3 in PA-l cells, the cloned
cDNA was subcloned into appropriate mammalian expression
vectors. We have successfully inserted the hZP3 into an
episomal vector, pREP4, which is mainly composed of a Rous
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sarcoma virus long terminal repeat (RSV LTR), Epstein Barr
virus OriP element (EBV OriP), EBNA-1 gene, SV40 poly A
element and the Hygromycin resistance gene (Fig 9) . There
are two major advantages by using pREP4 as vector to express
foreign cDNA in mammalian cells. First of all, the RSV LTR
is active in a broad range of mammalian cell types,
•
therefore, the foreign gene or cDNA inserted into the pREP4
vector is capable of being transfected into and expressed in
a variety of mammalian cells. Second, the inherent EBV OriP
element and EBNA-1 gene maintain and allow the introduced
vector to be propagated for the expression of foreign genes
in adherent mammalian cells [81] .

B. Expression of hZP3
1. Stable transfection

The biological activity of the ZP3 (i.e. the receptor
ligand ability) has been reported to be related to its
carbohydrate side chains [28,40,48,49,98,100], therefore,
the glycosylation of the protein is critical for the
production of a recombinant hZP3 with biological function.
Therefore, a human ovarian tumor cell line, PA-1, was
selected as the host cell for the production of recombinant
hZP3 glycoprotein based on three facts: (1) it is an ovarian
cell line,

(2) it is of human origin, and (3) it is known to

produce glycosylated native proteins (lactosaminoglycancarrier glycoprotein with 80-120 KDa molecular mass; and
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heparin-binding protein which is about 44 kDa)

[77,78], and

recombinant proteins (recombinant fibronectin)

[111] .

After the cloned hZP3/pREP4 expression vector DNA
construct was introduced into PA-1 cells by the calcium
phosphate-mediated method and hygromycin selection, the
single colonies of stable-transfected cells were identified
and selected by three criteria: PCR (Fig 11), RT-PCR (Fig
12), and ELISA (Table 1).
Based on the results, the expression vector construct
was integrated into the genomic DNA of PA-1 cell, and might
be integrated into the chromosomal DNA. First of all, a
specifically amplified product (954 bp) was identified by
PCR using CH-1/S1 primers in the transfected cells, but was
not found in the non-transfected cells, suggesting the
integration of the hZP3 cDNA into the genomic DNA (Fig 11).
Second, total cytoplasmic RNA (as well as small DNAs other
than chromosomal DNA) was isolated by the sucrose gradient
method as described previously, and a single specifically
amplified product was identified by RT-PCR using CH-1/S1
primers in the transfected cells. However, nothing was found
by the same application in the cells transfected with vector
(Fig 12) or in the non-transfected cells (Data not shown).
Therefore, no genomic DNA in the cytoplasm was amplified by
PCR using CH-1/S1 primers, otherwise there ought to be some
background observed in the RT-PCR identification (Fig 12).
Third, it is believed that the introduced foreign DNA was
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not stable in the cytoplasm and ought to be digested by
DNase inside the cells in a few days.
The mechanism of the integration of the expression
vector DNA construct (hZP3/pREP4) into the chromosomal DNA
of the host cells (PA-1) is not clear, but it is believed to
be a non-specific integration. Nevertheless, the Rous
sarcoma virus long terminal repeat (LTR) inherent in the
expression vector (episomal vector, pREP4) is able to be
inserted into the chromosomal DNA by transposition [121].
Therefore, the vector-dependent mechanism (Rous sarcoma
virus LTR) may be responsible for the integration of
hZP3/pREP4 construct into the PA-1 genomic DNA [121].

2. Expression of hZP3

The in vitro transcription/translation experiment
demonstrated that our cDNA of hZP3 was able to produce a
nonglycosylated protein which exhibited full-length protein
backbone of the hZP3 glycoprotein (47 kDa. Fig 10). In
addition, a second product with a molecular mass about 40
kDa was also observed (Fig 10). We do not know whether this
protein has any physiological meaning or just represents a
non-completed product of the transcription or translation
reaction.
In order to produce glycosylated hZP3, the cloned cDNA
was introduced into and expressed in PA-1 cells. Culture
medium was collected and the recombinant hZP3 was purified
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by WGA-Sepharose chromatography and anti-WGA immunoaffinity
chromatography as described in Methods (Fig 13). Centriprep30 and Centricone-30 were used to concentrate protein
following manufacturer's instruction.
Although there were still many different glyco
proteins, the WGA-purified glycoprotein solution showed the
banding at the expected position (65 kD) by SDS-PAGE and
silver staining (Fig 14). The SDS-PAGE by silver staining
could not be effectively analyzed for the identification of
the secreted hZP3 glycoprotein because of the following
reasons. First, the test and control solutions were still
composed of many proteins including some proteins with the
similar molecular mass (65 kDa). Second, the amount of re
combinant glycoprotein produced may not be enough for the
identification. Finally, silver staining is not able to
specifically identify the hZP3 from other proteins (Fig 14) .
Therefore, Western blot analysis with antibody (Ab5a)
was performed and this further identified the hybridization
at 65 kDa and 100 kDa (Fig 15). Moreover, solubilized human
zonae demonstrated the exactly same size of hybridization at
around 65 kDa by Western blot analysis, suggesting that hZP3
is 65 KDa (Fig 15). In fact, a very weak band at 100 kDa was
also hybridized in the solubilized zonae, suggesting this
high molecular weight protein has less immunogenicity than
the 65 kDa protein and may be related to hZP3.
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There are many possibilities for the 100 kDa (or
heavier) glycoprotein which was produced by the transfected
cells and also demonstrated immunogenicity in the Western
blot analysis (Fig 15) . According to Shabanowitz, a band
heavier than 100 kDa and in the similar position as ours was
also hybridized by Western blot analysis when solubilized
human zonae proteins were used as sample [53]. Shabanowitz
explained this band may be a dimer of ZP1 and ZP2 [53] . In
fact, it does not seem to be accurate if Dean's estimation
about the molecular mass of hZP proteins is correct (hZP2
about 76 kDa and hZPl about 100 kDa) [40]. More importantly,
it does not agree with our understanding of the hZP proteins
that ZP2 and ZP3 are believed to bind together as dimer, but
not ZP1 and ZP2 [7,39] .
On the other hand, a transfected hamster ovarian cell
line (CHO) was produced recently by the introduction of a
hZP3 "minigene" construct [62]. The produced recombinant
glycoprotein (55 kDa) was smaller than the native hZP3 and
the most important biological activity of the hZP3, i.e. the
sperm ligand activity, was not reported. Nevertheless, a
band heavier than 100 kDa whose position was similar to our
result, was also stained by western blot analysis shown in
their figure [62]. This indicated the possibility that the
protein (100 kDa or heavier) could be somehow related to ZP3
glycoprotein, especially since both of them (65 kDa and 100
kDa) demonstrated immunogenicity to ZP3 antibodies.
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In addition, it had been shown that PA-1 tumor cell
produced another recombinant glycoprotein (fibronectin) with
heavier molecular mass than its native one [111]. It could
be explained by the activation of the glycosylation system
in the tumor cell itself. Therefore, it is still not clear
whether the 100 kDa (or heavier) glycoprotein produced is
really hZP3-related glycoprotein or a by-product due to
overglycosylation of the hZP3 protein in tumor cells.
By using 3H-galactose, a metabolic labelling study
was performed as described in Methods to identify the newly
biosynthesized and secreted glycoproteins. In the ^-ga
lactose labelling metabolic study, the 100 kDa (or heavier)
glycoprotein was distinct and obviously a product of the
transfected cells (Fig 16) which implied that it is either a
product of the introduced hZP3/pREP4 DNA construct or
induced by the products of the introduced DNA construct in
PA-1 cells. In addition, the total amount of glycoproteins
produced in the transfected cells was about 3.29 times more
than that in the non-transfected cells, and there may be a
large amount of the biosynthesized recombinant glycoproteins
(up to 10 millions cpm) which have not been secreted and are
left inside the transfected cells (Table 2).
According to the results of SDS-PAGE with silver stain
(Fig 14), 3H-galactose labelling metabolic study (Fig 16),
and especially Western blot analysis (Fig 15), the molecular
mass of the recombinant hZP3 glycoproteins produced by the
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transfected cells of human ovarian cell line (PA-1) was
about 65 kDa. In addition, the non-glycosylated polypeptide
backbone of hZP3 is 47 kDa as mentioned previously and a
complex type N-linked or O-linked oligosaccharide is about
3-4 kDa. In this case, it implies that there ought to be
four to six carbohydrate side chains (account for 18 kDa) in
one molecule of hZP3 glycoprotein. And at least one or some
of them must be O-linked carbohydrate side chains because it
is believed that it is the O-linked carbohydrate side chains
that are responsible for the biological activity of the hZP3
glycoprotein as receptor ligand of sperm cell [39,48] .
Carbohydrate chains are believed to be able to
stabilize the protein itself and a hZP3 molecule contained
at least 18 kDa of carbohydrate side chains according to our
results. This may be one of the reasons why the half-life of
the zona pellucida proteins is so long (>100 hr and may be
up to 10 days)

[39,40]. On the other hand, zona pellucida

proteins may polymerize and are organized as a filament
structure [5,7,44]. This implies that there may be distinct
molecular structure of the zona pellucida proteins in their
polypeptide backbone that will enhance their protein-protein
polymerization, or some specific metabolic pathway or
intracellular signal transduction mechanism may exist to
assemble this special organelle in the female germ cell
during development.
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C. Biological functions of hZP3

As mentioned before, hZP3 is expected to be the first
receptor to bind and recognize sperm, and the hemizona assay
(HZA) has been proven to be the best method to test the
biological function of binding and recognition between sperm
and egg [40,91]. Indeed, the biological activity of the
recombinant hZP3 demonstrated significant results in the
hemizona assay (Fig 17), and it was also demonstrated to be
effective in the acrosome reaction assay (AR) in preliminary
experiments. Ham's F-10 and the culture medium from non
transfected cells were used as negative controls to do a
reasonable adjustment of the results in the bio-assays (HZA
and AR). In addition, the paired t-test was applied to
statistically analyze the results between test and control
groups in the HZA. These results strongly suggest that hZP3
is really functioning as a receptor to bind sperm as well as
inducer of the acrosome reaction.
To further investigate the molecular mechanisms of
human sperm-zona pellucida interaction, future research will
involve the following: (1) studies of signal transduction
events after the recognition and binding of the receptors of
zona pellucida and sperm cell at the cellular level (for
example, Ca2+ influx), (2) dose-dependent and time-course
studies of the recombinant hZP3 in the Hemizona assay (HZA)
and Acrosome reaction assay (AR), and (3) further
purification (i.e. immunoaffinity) of the recombinant hZP3

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

99

and amino acid sequencing.

D. Conclusion

In conclusion, this study has fulfilled our specific
aims based on the following experiment results:
(1) The full-length cDNA of hZP3 has been successfully
produced, identified and subcloned into expression vectors
as proposed.
(2) A stable-transfected cell line has been produced
by introduction of the hZP3/expression vector DNA construct
into a human ovarian cell line, PA-1, and identified based
on the following criteria: PCR, RT-PCR, and ELISA.
(3) The isolation of a secreted recombinant
glycoprotein has been accomplished by WGA-Lectin
chromatography and anti-WGA immunoaffinity chromatography.
(4) The secreted recombinant hZP3 has been identified
by the following criteria: immunogenicity (ELISA and Western
blot analysis) , molecular mass (in vitro translation, and
SDS-PAGE with silver stain) , and biological characterization
(HZA and AR) . In addition, in the biological
characterization, the recombinant glycoprotein demonstrated
the dual functions of hZP3 (i .e .sperm-binding and induction
of acrosome reaction) .
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APPENDIX I
Sequence of the cDNA of hZP3 (J. Dean) and the locations and
orientations of the primers and probe designed for this
study (attach behind)
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APPENDIX II
Estimated cell number in various culture dishes

Internal
radius(cm)

Area(cm2)
(per well)

Cell Number(x million)
(100% confluence)

24 well
cluster
(Costar)

0 .75

1.77

0.5

6 well
cluster
(Costar)

1.70

9.08

2.57

Petri dish
(100x20mm)
(Corning)

4 .00

50.26

14
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APPENDIX III
Autosequencing of the RT-PCR product (cDNA of hZP3) by
taking advantage of the T3 promoter inherent in the hZP3/PSK
DNA construct
This sequence read was reversed and complementary to
that of hZP3 cDNA published by J. Dean (see Appendix I) .
The position of the first base (base 1278) of hZP3
cDNA identified was marked in the figure attached behind.
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APPENDIX IV
Autosequencing of the RT-PCR product (cDNA of hZP3) by
taking advantage of the T7 promoter inherent in the hZP3/PSK
DNA construct
The position of the first base (base 1) of the hZP3
cDNA identified was marked in the figure attached behind.
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APPENDIX V
Sperm motility examination
Conclusion: There was no significant toxic effect of the
recombinant hZP3 (rZP3) found on the sperm motility.

% Motility
Ham’s

79 ± 2

rZP3 (1:4)

72 ± 3.5

NTM
rZP3 (1:4)

74 ± .5
76 ±1

Ham's

71 ± 2

rZP3 (1:8)

64 ± 4

NTM

77 ± 2

rZP3 (1:8)

70 ±3.1
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APPENDIX VI
Computer print-out of the statistic analysis of the
hemizona assay results by single (paired) t-test.
The larger the |t| score and the smaller the p score (twotailed test) are, the more significant the results
demonstrate.
6 cases with 2 variables

1
1
1
1
“
11
|2
I3
|4
15
|6

1

c
54.000
26.000
41.000
30.000
45.000
20.000

2
T

C: Control group (the non-transfected medium)
T: Test group (1:4 dilution of rZP3 solution)

29.000

Number of sperm cells bound to the identical
pairs of hemizonae (6 pairs)

0.000
42.000
15.000
22.000
23.000

I__ L

i

I
| css/3:
| basic
| stats

Single t-Tests
N. of Cases - 6
(MD casewlse deleted)
... ,

,

1
I
i
1
-2.6446534129700 j
i
t

|
i

T-C

i
| css/3:
| basic
| stats

j
i

(

|

1
1
i
1
.04571945965290 |
i
p

n

'
Single t-Tests
N. of Cases - 6
(HD casewlse deleted)
i
1
E(X-Y)
| D(X-Y)
T-C

-14.166666666667

| 13.1212301093170
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6

1
i

A PPE N D IX V II
Other informations

1) . 1 pmol of 1.3 kb of double-strands DNA = 0.48 fig
2). 50 pmol of 21 bp primer = 0.5
reaction volume

in a 50 ^1 final

3) . 1 A260 unit of 10 bases linker = 50 fig
4) . 1 fiCi = 2.2 x 106 cpm
5) . [RNA] =

a 260 x

40.0 ^g/ml

6). [DNA] = A260 x 50.0 fig/ml
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APPENDIX VIII
Comparison of the length of hZP3 gene and its cDNA.
The human ZP3 gene is composed of eight exons and
corresponds to 18.3 kilobase-pairs of DNA, while the cDNA of
hZP3 which is produced by RT-PCR is only 1.3 kilobase-pairs
long.

1 Kb

Human ZP3 cDNA
Exon 1

3 45

67

Human ZP3 Gene
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